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Notes on nomenclature and
style
All nomenclature uses accepted standard symbols as far as pos-
sible. Units are typeset according to SI. Element nomenclature
follows IUPAC rules. Biochemical nomenclature follows IUB rec-
ommendations.
Carbon atoms belonging to a molecule are addressed as ’C-
n’ where ’C’ stands for carbon and n denotes the atom number
according to IUPAC rules. The total number of carbon atoms
of a molecule is abbreviated as ’Cn’ with ’C’ again standing for
carbon and n being the carbon atom count.
A redox reaction of the form Xred+Yox −→ Xox+Yred is often
additionally given in a simplified form as X −→ Y to emphasize
the vectorial flow of electrons.
Enzyme names are often typeset as ’sProtein’ with ’s’ denoting
the source species where ’s’ can be substituted by either ’b’ for
bovine, ’h’ for human, or ’r’ for rat proteins. Fission yeast proteins
are not labeled by a specific prefix subscript. Species names as
well as gene names are typeset in italics according to general rules.
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Abstract
Genetically modified microbial organisms are being increasingly
used for the industrial production of complicated chemical com-
pounds such as steroids; however, prior to this work there have
been few reports on the use of the fission yeast Schizosaccharo-
myces pombe for this purpose. In the human adrenal, the mito-
chondrial P450 enzyme CYP11B1 catalyzes the conversion of 11-
deoxycortisol to cortisol while the microsomal P450s CYP17A1
and CYP21A1 together with the aldo-keto reductase 3β-HSD per-
form the crucial conversion of pregnenolone to either mineralocor-
ticoid, glucocorticoid, and sex steroid precursors. Expression of
these P450s in fission yeast resulted in strains that show a consid-
erable biotransformation activity in whole-cell assays carried out
over several days. The host is capable of supplying this enzymes
with the reducing equivalents necessary for steroid hydroxylation
activity indifferent of whether the P450s are localized in mito-
chondria or in the endoplasmic reticulum.
xi
Zusammenfassung
Gentechnisch vera¨nderte Organismen werden zunehmend fu¨r die
industrielle Produktion komplizierter chemischer Verbindungen
wie Steroide eingesetzt, jedoch gab es vor dieser Arbeit rela-
tiv wenige Studien u¨ber die Verwendung der Spalthefe Schizo-
saccharomyces pombe fu¨r diesen Zweck. In der menschlichen
Nebenniere katalisiert das mitochondriale P450 Enzym CYP11B1
die Umwandlung von 11-Desoxycortisol zu Cortisol, wa¨hrend die
mikrosomalen P450 Enzyme CYP17A1 und CYP21A1 zusammen
mit der Aldo-Keto Reduktase 3β-HSD die essentielle Umwand-
lung von Pregnenolon zu Mineralokortikoid-, Glukokortikoid- und
Sexualsteroid-Vorstufen katalysieren. Die Expression der genan-
nten P450 Enzyme in der Spalthefe fu¨hrt zu Sta¨mmen, welche eine
beachtliche Ganzzell-Biotransformationsaktivita¨t u¨ber mehrere
Tagen zeigen. Der Wirtsorganismus ist dabei in der Lage, die fu¨r
die Steroidhydroxylierung notwendigen Reduktionsa¨quivalente
bereitzustellen, gleichgu¨ltig, ob es sich dabei um mitochondriale
oder mikrosomale P450 handelt.
xii
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Chapter 1
Introduction
1.1 Steroids as chemical entities
Biosynthetically seen, steroids are the product of successive con-
densation reactions of the C5-body isopentenyl pyrophosphate
and its double bond isomer dimethylallyl pyrophosphate yield-
ing C5n-bodies. Squalene, precursor to cholesterol and, therefore,
to all steroid structures, is synthesized by the condensation of
two farnesyl pyrophosphate units which are C15-bodies belonging
to sesquiterpenes. Because squalene is a C30-body, the biosyn-
thetic class it is assigned to is called triterpenes. The oxida-
tion of squalene by the squalene monooxygenase (SQLE in Homo
sapiens, erg1 in fission yeast) is followed by the generation of
a carbocation through the action of lanosterol synthase (LSS in
Homo sapiens, erg7 in fission yeast) which immediately induces
a group migration-based rearrangement yielding lanosterol (Fig.
1.1). A nineteen-step reaction sequence then transforms lanos-
terol to cholesterol which is a C27-body (Gaylor, 2002). Func-
tionally seen, steroids belong to the lipid class.
According to the nomenclature of steroids (IUPAC-IUB, 1989),
the carbon atom numbering and ring letters follow the scheme
shown in Figure 1.2. Steroids are defined as structures derived
from cyclopentaphenanthrene and often possess two methyl groups
1
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Figure 1.1: Chemical structure of lanos-
terol.
at C-10 and C-13 and possibly an alkyl side chain at C-17. Mem-
bers of the steroid subset that bear a hydroxy group at C-3 are
called sterols.
The stereochemistry of the steroid’s accessory groups is de-
scriptively addressed by assigning to them either the suffix ’α’ or
’β’, depending on whether the group is located below or above the
ring plane. The exemplary conformer model of cholesterol (Fig.
1.3) shows that the absolute spatial orientation of the group’s
covalent bond axis linking it to the respective ring is indeed not
homogenous among the α or β-groups due to conformational dis-
tortion of the rings. For instance, the methyl groups at C-10 and
C-13 and the hydroxy group at C-3 point to different directions
in space although they are assigned to the β-orientation.
Counting the number of the potential stereomeric centers of
the condensed ring structure displayed in Figure 1.2, yields 4
for the A-ring, 2 for the B-ring, 2 for the C-ring, and 2 for
the D-ring which totals to 10. At each of the stereomeric cen-
ters a substituent can adopt either the α or the β orientation,
yielding a total of 20 possible substitution sites. The permuta-
Figure 1.2: Ring designa-
tions and atom numbering
in steroids.
2
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Figure 1.3: An exemplary conformer of
cholesterol. The model was rendered using
the open-source chemical editor program
Avogadro (http://avogadro.openmolecules.
net/wiki/Main Page) combined with openly
available 3D-coordinates from a conformer set
published by the PubChem project (http://
pubchem.ncbi.nlm.nih.gov/). The conformer
structures in the PubChem database were
computed by applying MMFF94 (Merck
molecular force field version 94, Halgren
(1996)) energy minimization.
tion of k substituents leads to 20!/(20 − k)! isomers which re-
sults in 20!/17! = 6840 different structures for already three sub-
stituents. This potential variability demonstrates how important
stereochemical control is in biosynthesis pathways.
A habit in trivial steroid nomenclature is to name steroids with
a double bond between C-5 and C-6 as ∆5-steroids. When the
double bond is located between C-4 and C-5, the steroids derived
thereof are named ∆4-steroids.
1.2 Adrenal steroids
The human adrenal is a source of various important steroids. The
gland consists of two histologically distinctive regions: the inner
medulla and the surrounding cortex whereby the later is com-
posed of three histologically distinguishable layers called the zona
glomerulosa, zona fasciculata, and the zona reticularis (Fig. 1.4).
Steroid biosynthesis takes place in the adrenal cortex where the
responsible enzymes are unequally distributed along the differ-
ent zones (see for instance Fig. 1.4B) thus yielding a spatially
3
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Figure 1.4: Histology of the human adrenal. Immunoreactivity for cytochrome b5 (A),
Immunoreactivity for CYP17A1 (B). C: capsule, ZG: zona glomerulosa, ZF: zona fasciculata,
ZR: zona reticularis, M: medula. Image source: Dharia et al. (2004).
varying steroid biosynthesis activity (Ghayee and Auchus, 2007).
The most inner part, the zona reticularis, produces C19 androgen
precursors such as DHEA and its sulfate (DHEA-SO –3 ), while
the middle layer, the zona fasciculata, and the outer layer, the
zona glomerulosa, mainly produce cortisol and aldosterone, re-
spectively.
Figure 1.5 shows a scheme of the main steroidogenic path-
ways occurring in the adrenal which are catalyzed by cytochrome
P450 enzymes and the aldo-keto reductase 3β-hydroxysteroid de-
hydrogenase (3β-HSD). Note that the steroid biosynthesis system
extends over two subcellular compartments, hence, some com-
pounds need to cross at least one membrane. The cytochrome
P450 enzymes CYP11A1, CYP11B1, and CYP11B2 are localized
in mitochondria while the microsomal CYP17A1 and CYP21A1
are associated with the endoplasmic reticulum (ER). Since the
larger part of microsomal P450s topologically faces the cytosol
(Poulos and Johnson, 2005), they act as cytosolic enzymes. All
shown P450s are able to catalyze more than one reaction. For
instance, the mitochondrial CYP11A1 hydroxylates at C-20 and
C-22 of cholesterol, the microsomal CYP17A1 catalyzes hydrox-
ylations and bond cleavage reactions, and CYP21A1, CYP11B1,
4
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Figure 1.5: Steroid biosynthesis pathways in the human adrenal. CYP: cytochrome P450,
HSD: hydroxysteroid dehydrogenase.
and CYP11B2 accept different substrates. Concerning variety,
the microsomal CYP17A1 offers the richest repertoire of physio-
logical reactions.
According to Ghayee and Auchus (2007), the metabolic steps
required for steroid hormone action in the human body consist
of:
1. cholesterol conversion to pregnenolone,
5
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2. pregnenolone conversion into various intermediates,
3. peripheral organ metabolism of precursors and/or physiolog-
ically active compounds,
4. specific metabolic effects in the target tissues,
5. degradative metabolism of steroids.
Some crucial steps were omitted in the above enumeration like the
availability of cholesterol, the systemic transport of cholesterol
by the lipoprotein system (Martini and Pallottini, 2007), and its
complex intracellular distribution (Prinz, 2007).
1.3 Clinical aspects of steroid biosynthesis
The specific effects caused by steroid action are often easily ob-
servable and it is not surprising that the pivotal studies on the
beneficial effects of prescribed adrenal hormones in the treat-
ment of rheumatid arthritis were gained more than 50 years ago
(Hench et al., 1949, 1950). Edward C. Kendall, Tadeus Re-
ichstein, and Philip S. Hench received the 1950 Nobel Prize in
Physiology or Medicine for their discoveries related to the hor-
mones of the adrenal cortex. Adverse effects of glucocorticos-
teroid therapy soon became evident after prolonged treatment
periods were applied (Boland and Headley, 1951) and even nowa-
days a lively debate about dosage and indications is carried out
(Bijlsma et al., 2003). However, the need for this class of com-
pounds is still high due to their use in dermatitis and inflamma-
tory chronic diseases (Barnes, 2006). The prominent physiologic
function of aldosterone is the increased retention of sodium by the
kidney (Freel and Connell, 2004) exerted via the mineralocorti-
coid receptor. Cortisol is involved in anti-inflammatory actions
and complex metabolic effects (Wang, 2005) exerted through the
6
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glucocorticoid receptor. Progesterone acts through the proges-
terone receptor and plays an important role in the menstrual
cycle and pregnancy (Daniel et al., 2009). Its effects were ex-
ploited in the form of oral contraceptives. Today, progesterone
is substituted by 2nd and 3rd-generation artificial derivatives like
levonorgestrel and norgestimate (Kulier et al., 2004). Further
important compounds are the C19 steroid DHEA and its sulfate,
which are usually transported to the testes or ovaries where sex
steroid biosynthesis is accomplished (Ghayee and Auchus, 2007).
Their effects on target tissues may become deleterious through the
action of testosterone, dihydrotestosterone and estrogen in breast
and prostate cancer (Dı´az-Chico et al., 2007; Carruba, 2007; Pen-
ning and Byrns, 2009).
Clinically seen, the most important P450 member in Figure
1.5 is CYP21A1. Its insufficiency is by far the most common
cause of congenital adrenal hyperplasia (CAH). The most life-
threatening form is the salt-wasting type leading to dehydration
(Ghayee and Auchus, 2007). The symptomatic level of CAH can
be correlated with the availability of other hormones which are
normally dependent on a physiological CYP21A1 function (see
Fig. 1.5). For instance, alterations of sex hormone levels as a
consequence of CAH can lead to various phenotypes with respect
to sex development and function (Ghayee and Auchus, 2007).
The CYP17A1-deficiency is another cause of CAH with an of-
ten similarly complex phenotypic appearance while a CYP11B1-
deficiency leads to CAH with distinctly increased androgen levels
(Ghayee and Auchus, 2007). Overproduction of steroid hormones
is known to occur in case of adrenal adenoma and carcinoma or
nodular hyperplasia. Classic examples for steroid overproduction
disorders are Cushing’s syndrome (hyperadrenocorticism, corti-
sol overproduction) and Conn’s syndrome (hyperaldosteronism,
aldosterone overproduction) showing some phenotypic symptoms
similar to CAH.
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The CYP11B subfamily might become interesting as a phar-
macological target because of the existence of hyperaldostero-
nism or hypercorticism syndromes. Although potential inhibitors
might play a role here, a couple of reasons hamper the commer-
cial breakthrough of such a strategy. First, a frequently encoun-
tered type of hypercorticism is the iatrogenic form caused by the
treatment of life-threatening illnesses, such as asthma, rheuma-
toid arthritis, systemic lupus, inflammatory bowel disease, some
allergies, and others (Hopkins and Leinung, 2005); a fact known
since many years (Kelly et al., 1972). Second, even in case of
adrenocortical tumors it seems that the human CYP17A1 might
be the main determinant of the Cushing syndrome (Enberg et al.,
2009). Third, due to the mentioned similarity between CYP11B1
and CYP11B2, the screening for a specific inhibitor for one of the
isoforms is difficult. However, the link between certain heart dis-
eases and aldosterone levels might generate additional appeal in
the near future to be concerned with the human CYP11B subfam-
ily (Bureik et al., 2002a). In fact, the pharmacological concept of
a P450 inhibitor drug was already successfully demonstrated for
CYP19A1 in the treatment of estrogen-dependent or adrenocor-
tical cancer (Schuster and Bernhardt, 2007).
Due to the effectiveness of their biological activity exerted at
low doses, steroids and steroid-derived drugs continue to be valu-
able pharmacological substances. Bureik and Bernhardt (2007)
state that the total steroid world market is probably worth more
than 10 billion $. For instance, several business reports issued
during the last years estimate the corticosteroid market for pain,
the topical treatment of dermatitis, and intranasal inhalation to
be worth more than one billion $ alone.1 In the US, a double digit
1http://www.ticker.com/Annualreport/CNCT/CNCT-2001.pdf,
http://www.advertisersservices.com/portfolio/11 November PP.pdf,
http://www.ticker.com/Annualreport/ABPI/ABPI-2005.pdf,
http://actonpharmaceuticals.com/files/news272/PR2010-01-05.pdf,
http://www.domainvc.com/PDF/SkinMedica%20FDA%20approval%20Desonate.pdf
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million number of corticosteroid containing nasal inhalations are
prescribed per year.2 Moreover, recent internet surveys summa-
rized by Kraska et al. (2010) point towards the existence of hun-
dreds of active websites selling anabolic androgenic steroids at
black market prices at least one order of magnitude higher than
for the licit compound. Hence, the world steroid black market
may account for one billion $ alone (Baron et al., 2007).
1.4 Steroid synthesis
Steroids were described more than 70 years ago by Heinrich O.
Wieland (Nobel prize 1927) and Adolf O. R. Windhaus (Nobel
prize 1928). Edward A. Doisy and Adolf F. Butenandt indepen-
dently isolated estrone, the first steroid hormone to be ever pu-
rified, from the urine of pregnant women in 1929 (Nicolaou and
Montagnon, 2008). Due to the beneficial therapeutic effects of
steroids, an ever increasing demand for steroids arose. The iso-
lation and purification as well as the production of steroids soon
became an active field of research.
1.4.1 Biocatalysis by P450s
It took 30 more years after their discovery until the nature of
one of the major enzyme groups involved in steroidogenesis was
resolved. Initially, Klingenberg (1958) discovered the cellular pig-
ments that showed a differential absorption at 450 nm when com-
plexed with carbon monoxide in the reduced state. Omura and
Sato (1962) characterized some properties of these particular cell
pigments which, due to their carbon monoxide differential spec-
trum, were provisionally designated as ’P450s’. Finally, Estra-
brook et al. (1963) could demonstrate that P450s were terminal
2http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/
PediatricAdvisoryCommittee/UCM204802.pdf
9
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oxidases involved in the adrenal steroid biosynthesis.
Soon, it became apparent that P450s co-radiated with popu-
lations during evolution with at least one representative in every
major branch of the tree of life. Therefore, a uniform nomencla-
ture system of the form
CYP n S m
was set up where ’CYP’ stands for ’cytochrome P450’, n is the
family integer, ’S’ being one or two letters designating the subfam-
ily, and m is the integer counter assigned to the individual P450
enzyme (Nelson, 2009). Unfortunately, the name cytochrome was
rather inattentively assigned to P450s and, even if they could fit
into the cytochrome b class, they are by no means electron trans-
fer proteins but terminal monooxygenases (IUB, 1992). In the
advent of faster and more reliable DNA sequencing techniques
the P450 nomenclature was heavily based on protein sequence
identity criteria. The arbitrary chosen 40 % or more identity
classifies P450s as belonging to one family while a 55 % iden-
tity clusters them into subfamilies (Nelson, 2006). However, the
thresholds are now rather regarded as a rule of thumb and phylo-
genetic clustering, which better reflects evolutionary order, led to
the establishment of P450 clans (Nelson, 2006). To date, a total
of more than 11000 P450 sequences are known (including vari-
ants and pseudogenes) which are spread among 196 bacterial, 12
archaean, 459 fungal, 62 protist, 126 plant, and 120 animal fam-
ilies (Nelson, 2009). The nearly ubiquitous CYP51 (lanosterol
14α-demethylase) might be the common ancestor to all existing
eukaryotic P450s (Nelson, 1999).
A query against the protein data bank3 results in more than
250 X-ray diffraction-gained spatial structures of P450s. In terms
of secondary/tertiary structure, P450s reflect their common an-
cestry. Most P450s are composed of 4 β-sheets (β5 is variable) and
3http://www.rcsb.org/pdb/home/home.do
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(a)
(b)
Figure 1.6: Topology and structure of P450s. Panel A shows a topological secondary struc-
ture map taken from Peterson and Graham (1998). Rectangles represent helices, arrows
β sheets, and lines are the connecting ’random’ coils. Panel B displays a recently pub-
lished CYP51 structure (Chen et al., 2009) complexed with an inhibitor (not shown here).
The rendering was done using the KING molecular viewer available from http://kinemage.
biochem.duke.edu/software/king.php. Secondary structures are indicated by capital letters
(α-helices) and the Greek ’β’ (β-strands). The asterisks denote the start and end of protein
strand discontinuation due to ambiguous diffraction signals.
13 α-helices (Peterson and Graham, 1998) and follow a topologi-
cal pattern similar to the one depicted in Figure 1.6A. Figure 1.6B
shows an exemplary 3D-structure of the Mycobacterium tubercu-
11
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losis CYP51 (Chen et al., 2009). The structural core of P450s
consists of the α-helices D, E, I, L, and α-helices J and K (Peter-
son and Graham, 1998), which are labeled in Figure 1.6B. Helix
K contains the absolute conserved motif GXXA which is thought
to stabilize the core structure while helix L contains the abso-
lutely required cysteine residue that acts as the fifth iron ligand.
Helices I and L contact the porphyrin-heme b prosthetic group
while some residues in the B and the I helices may contact the
substrate (Guengerich, 2001). Substrate-protein interaction pre-
sumably takes place at the substrate-recognition-sequences that
were postulated more than 25 years ago by Gotoh (1992) based
on sequence alignments. Their role is increasingly supported by
experimental data (Guengerich, 2001).
With respect to their chemical composition P450s belong to
the metalloproteins. The iron atom is coordinated by the four
pyrrole nitrogen atoms of a heme B and the above mentioned,
highly conserved cysteine residue of the protein backbone. In the
sense of coordination chemistry, ligands to the iron atom form
the first coordination shell also designated as a bioinorganic motif
(Degtyarenko, 2000). The bioinorganic motif of P450s is denoted
as heme-thiolate motif and can be written as
[Fe 3+(N−por)4
γS−Cys]
with the iron being shown in the ferric state. The sixth ligand to
the ferric iron can be a weak ligand like a hydroxyl group from an
adjacent amino acid residue or even water (Kumaki and Nebert,
1978). For instance, carbon monoxide acts as the sixth ligand of
the first coordination shell in the reaction leading to the carbon
monoxide difference spectrum while in the general case of bio-
catalysis oxygen plays this role. According to ligand field theory,
iron ([Ar] 3d6 4s2) in the ferric ([Ar] 3d5) and ferrous ([Ar] 3d6)
state can undergo a low-spin/high-spin transition upon binding of
a sixth ligand due to energy splitting of the 3d orbital in the octa-
12
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hedral complex (Cotton andWilson, 1976). The high-spin state of
the ferrous iron consists of 4 unpaired electrons distributed along
two different energy levels of molecular orbitals (in contrast to
the low-spin or spin-paired state). The extent to which energy
splitting occurs depends on the nature of the ligand; however,
a high-spin iron is not necessarily required for catalysis (Guen-
gerich, 2001). Strong ligands like the CN – -ion usually lead to
low-spin states.
The reaction scheme shown in Figure 1.7 illustrates the pre-
sumed catalytic mechanism of P450s (see Guengerich (2001) and
Guengerich (2007) for further information). Although this scheme
was extensively used throughout the literature, it should not be
seen as committing in explaining P450 function. It offers neither
universality nor certainty in most of its parts, however, it is a
good starting point to understand P450 action. The cycle starts
with iron being in the ferric state and the substrate binding to the
Figure 1.7: Hypothetical P450 reaction cycle leading to the oxygenation of a substrate atom.
Reactions denoted with a number are regarded as productive steps while reactions denoted
with a letter (including A1, A2, and A3) are seen as abortive exit paths. R: atom or group
within the substrate molecule, RH: substrate, image source: Guengerich (2001).
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P450 (step 1). The iron atom can but needs not to perform the
low-spin/high-spin conversion at this moment. Step 2 comprises
the reduction to the ferrous state by an electron transferred from
NADH or NADPH via an electron transfer protein (see below).
Step 1 is not required for step 2 to occur and is shown before just
to illustrate that it is faster. Moreover, substrate binding and
dissociation can take place at different steps of the catalytic cycle
(Isin and Guengerich, 2008). Ferrous iron binds molecular oxygen
(step 3) and then receives the second electron (step 4) from an
electron transfer protein which can be different from the one used
in step 2. Beyond step 3, the characterization of the individual en-
zymatic states is uncertain and controversial (Guengerich, 2001,
2007). The [Fe 2+O2] as well as the [Fe
2+O2]
– complexes are un-
stable and generate superoxide anions and finally H2O2 through
the abortive steps A1 to A3. In case A1 to A3 do not take place,
a proton attaches to the oxygen radical forming a ferrous peroxo-
complex ([Fe 2+OOH], step 5) which either generates H2O2 (step
B) or undergoes dehydration to yield a [FeO] 3+-complex (step 6).
The precise electronic configuration of [FeO] 3+ is not known al-
though some authors denote this as FeV−O (Guengerich, 2001).
The homologous peroxidase complex rather points toward Fe 4+
and a one-electron deficiency delocalized in the porphyrin-ring
system (Guengerich, 2001). The [FeO] 3+-complex is apparently
used in most P450 reactions. Further reduction and addition of
protons can lead to water formation in the abortive step C. How-
ever, abstraction of one hydrogen from the substrate generates a
substrate radical (step 7) which then receives the hydroxyl group
in step 8 to finally dissociate from the enzyme in step 9. Guen-
gerich (2001) offers a general mechanism of the form
[FeO] 3+ + R3C−H −→ [FeOH]
3+·R3C
· −→ Fe 3+ + R3C−OH (1.1)
that rationalizes the following observed P450 reactions:
 carbon hydroxylation,
14
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 heteroatom release (N, S, and O-dealkylations),
 heteroatom oxygenation,
 epoxidation/group migration.
Dehydrogenations share the hydrogen abstraction step with car-
bon hydroxylations, however, they terminate by stripping off a
vicinal proton thus yielding a double bond. There are additional
reactions catalyzed by P450s that cannot be explained by Equa-
tion 1.1. Indeed, the chemical properties of the different P450 iron
complexes are diverse (Mansuy, 1998). For instance, Fe 3+ is not
quite reactive but due to the cysteinyl ligand is able to transfer
an electron to peroxides, e.g., prostacyclin synthase (CYP8A1)
without involvement of any electron transfer proteins. The fer-
rous P450 is more electron rich and can participate in reactions
like
 reduction of nitro compounds,
 N-oxide reduction,
 reductive dehalogenation.
Eventually, the [Fe 2+O2]
– -complex is nucleophilic and may re-
act with substances containing an electrophilic center (Mansuy,
1998). An important role of the protonated peroxo complex
[Fe 2+OOH] is in the carbon-carbon bond cleavage reactions of
CYP17A1 and CYP19A1 (Ahmed and Owen, 1998). Technically,
both the relative position of the substrate to the heme-iron as
well as the various iron species may be responsible for the chem-
ical variety of P450 catalysis. It seems that a coherent, general
P450 mechanism seems to be far away nowadays, nevertheless,
the mechanistic variety is what makes P450s so exciting.
Except for the Fe 3+-catalyzers (see above), the electron supply
of P450s must be assured during catalysis. With one exception
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where electrons are derived from pyruvate or coenzyme A, all
P450-systems utilize NADH or NADPH as electron donors that
are linked to the terminal P450 by electron transfer proteins (Han-
nemann et al., 2007). To date, 10 different P450 electron transfer
classes can be distinguished of which the highest diversity is ex-
pectably found in bacteria. All P450s shown in Figure 1.5 can be
assigned to two classes. The mitochondrial CYP11A1, CYP11B1,
and CYP11B2 are embedded in a class I electron transfer system
consisting of NADPH, adrenodoxin reductase (AdR), and adren-
odoxin (Adx) which performs the following reactions


AdRox +NADPH +H
+ −−→ AdRred +NADP
+
AdRred + 2Adxox −−→ AdRox + 2Adxred
CYPox + S −−⇀↽− [CYPox·S]
2Adxred + [CYPox·S] + O2 + 2H
+ −−→ 2Adxox +CYPox + P+H2O


, (1.2)
where S denotes the substrate and P the product. Using the
simplified redox scheme, the above equation might be rewritten
as
NADPH −→ AdR −→ 2Adx −→ CYP −→ S.
Hereby, the substrate association to the P450 is shown before Adx
binding, however, substrates may bind after reduction by Adx.
The 57 kDa AdR, which is loosely associated with the inner mi-
tochondrial membrane, possesses a bipartite FMN-FAD reaction
center enabling it to accept two electrons from NADPH. The elec-
trons are then sequentially transferred to the one-electron storing
14 kDa Adx which shuttles them towards the terminal P450. To
simplify the above reaction, the two-electron transfer was shown
as one reaction. The interaction between AdR and Adx occurs
mainly through electrostatics comprising basic residues located
on AdR and acidic residues near the Fe2S2-center on Adx (Miller,
2005). Both CYP21A1 and CYP17A1 are embedded in a class
II electron transfer system consisting of NADPH and cytochrome
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P450 reductase (CPR) that catalyze


CPRox +NADPH +H
+ −−→ CPRred +NADP
+
CYPox + S −−⇀↽− [CYPox·S]
CPRred + [CYPox·S] + O2 + 2H
+ −−⇀↽− CPRred +CYPox + P+H2O


(1.3)
Again, substrate binding is shown before reduction by CPR which
appears realistic in light of Kd-values in the micromolar range
(Nakajin et al., 1981; Kominami et al., 1988). The vectorial elec-
tron flow in class II systems can be simplified as
NADPH −→ CPR −→ CYP −→ S.
Electrons from NADPH are transferred by the 77 kDa CPR via
electrostatic interaction to the P450 and finally to the substrate
(Miller, 2005). It is not quite clear whether CYP17A1 might
require accessory electron transfer through cytochrome b5 in order
to carry out the 17/20-lyase reaction (Auchus et al., 1998).
The steroidal products of P450s are predominantly accumu-
lated in tissues and body fluids of higher eukaryotes. In the early
days of steroid discovery, biological raw materials were hence often
the starting point for tedious purification processes. For instance,
less than 70 mg of estriol were isolated from 200 L of human preg-
nancy urine by Marrian (1930), 100 mg of equilin were isolated
from 7 t of mare urine by A. Girard 1932 (Cartland and Meyer,
1935), 25 mg of estradiol was purified from 4 t of fresh sow ovaries
by Edward A. Doisy in 1936 (Nicolaou and Montagnon, 2008)
while in 1934 20 mg of progesterone could be isolated from 625 kg
of sow ovaries by the German-based Schering Laboratories (Nico-
laou and Montagnon, 2008). The above numbers demonstrate
that an enormous amount of work was necessary to yield amaz-
ingly low quantities of pure steroids. This fact renders any direct
isolation attempt of steroids from naturally occurring biomass
sources at kilogram scale commercially unattractive. However,
the great demand for steroids that followed the pivotal studies by
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Hench et al. (1949) forced the implementation of commercially
viable production processes.
1.4.2 Chemical synthesis
The first total synthesis of a steroid (equilenin) was achieved as
early as 1939 by Bachmann, Cole, and Wilds while estrone was
synthesized in 1948 and non-aromatic steroids followed during
the 1950s (Hirschmann, 1992). The total synthesis of cortisone
by Woodward et al. (1951) marks an important milestone since it
was shown that even stereochemically demanding structures could
be built from relatively simple compounds. Later on, during the
1970s, the first biomimetic synthesis approach was applied to the
synthesis of progesterone by William S. Johnson while Peter K.
C. Vollhardt showed an astonishingly simple total synthesis of
estrone (Nicolaou and Montagnon, 2008).
Despite these academic achievements, commercially viable
steroid syntheses never relied on a total synthesis approach alone
but rather started with naturally occurring structures and fol-
lowed a partial synthesis scheme. One of the most influential
approaches was designed for progesterone by Rusell E. Marker
starting from diosgenin (Fig. 1.8A) which can be isolated from
the Mexican yam (Dioscorea mexicana). Carl Djerassi managed
to partially synthesize cortisone from diosgenin in 1951, the same
year in which Woodward had presented his total synthesis of the
same steroid (Nicolaou and Montagnon, 2008). Cortisone could
first be commercially provided by the Merck Laboratories in 1944
using dioxycholic acid (Fig. 1.8B) and derivatives thereof as start-
ing material (Hirschmann, 1992). The Schering corporation soon
followed with a partial synthesis of cortisone using bile acid as raw
material and extended their portfolio to prednisone, prednisolone,
and dexamethasone but increasingly included biotransformation
steps in their processes (Herzog and Oliveto, 1992). The Schering
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(a) Diosgenin (b) Deoxycholic acid
Figure 1.8: Starting structures for commercially viable partial syntheses of steroids.
corporation was second to Merck to introduce steroid formula-
tions on the market and cortisone acetate was already produced
at around 100 kg per month by that time (Herzog and Oliveto,
1992).
As mentioned, biotransformation of steroids became increas-
ingly interesting for the industry. Some industrially useful mi-
croorganisms are certain corynebacteria (21-deacetylation),Flavo-
bacterium dehydrogenans (11β-deacetylation), Pestalotia foedans,
andGlomerella cingulata (11α-hydroxylation) as reported by Her-
zog and Oliveto (1992). At the Squibb Institute for Medical
Research, the microbial hydroxylation of progesterone was pub-
lished in 1952 (Fried, 1992). During the same year, chemists from
Upjohn demonstrated the 11β-hydroxylation of 11-deoxycortisol
by Streptomyces fradiae (Colingsworth et al., 1953), the 11α-
hydroxylation of progesterone by Rhizopus arrhizus, and the par-
tial synthesis of triamcinolone using Arthrobacter roseochromo-
genus (Fried, 1992). Another commercially useful biotransforma-
tion step is the 11β-hydroxylation of steroids by Curvularia lu-
nata of which even the responsible P450 could be purified (Suzuki
et al., 1993). More information on microbial steroid biotransfor-
mations can be found in Bureik and Bernhardt (2007). It is obvi-
ous that microbial biotransformation steps found their way into
commercially viable partial syntheses right from the beginning of
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steroid production by chemical and pharmaceutical companies.
1.5 The rationale for this work
1.5.1 Focus on recombinant whole-cell biotransforma-
tion
It often comes to oversimplification when balancing the pros and
cons of a biotechnological process. Some arguments often men-
tioned in favor of microbial biotransformation are
 stereospecifity due to the enzymatic nature of catalysis,
 energy-saving because the process can be carried out at mod-
erate temperatures and pressures,
 low safety-risk processes as a consequence of the above points
and due to the absence of potentially harmful organic sub-
stances,
 environmentally more friendly due to the above mentioned
points.
Each of the above arguments turns out to be very differently
assessed when thoroughly analyzed.
For instance, stereospecifity was previously shown to be some-
times controllable in organic synthesis by different means. One
opportunity is the biomimetic approach simultaneously giving rise
to several correct stereomeric carbon centers. This technique
was firstly applied by Johnson et al. (1971) to synthesize pro-
gesterone at 12 % efficiency and cortisol acetate at considerable
yields (Johnson et al., 1980).
The energy-saving argument needs a thorough analysis with
the particular process at hand–a rather utopian situation, since
industrial processes are rarely disclosed. Nevertheless, many rea-
sons can lead to considerable energy consumption by a microbial
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process: sterilization of bioreactors and accessory piping and de-
vices, cooling of bioreactors, agitation energy and energy demand
of the system’s pumps, motors, and actuators. It should not be
forgotten that many chemical steroid syntheses, either complete
or partial, can be carried out at atmospheric pressure (see for
instance all references in Sec. 1.4.2).
Indeed, the safety risk of a microbial process appears greatly
reduced compared to classical organic synthesis techniques due
to reduced use of potentially harmful chemical compounds. How-
ever, biological safety measures may be neglected only in case a
GRAS4 status has been granted to the production organism and
are otherwise of concern. Steroids possess a lower solubility in
aqueous solutions than in organic solvents implying the use of
organic solvent-based liquid-liquid extraction (LLE) procedures
in order to isolate the steroid from the culture broth. Potential
sideproducts formed by the biomass may necessitate further sepa-
ration leading to increased use of solvents. Eventually, the hazard
risk associated with this techniques is for sure considerable while
the risk owing to high pressure vapor sterilization may likewise
not be neglected.
If the above paragraphs obscure the usefulness of biotransfor-
mation, the question is why then focus on it? The answer starts
with a simple fact. An important aspect of industrial processes
is to be profitable. If costs do steadily rise during operation, an
equally steady growing need to further increase the process ef-
ficiency will arise. Since we deal here with processes that are
run over decades, development has been carried out over several
years, often during runtime, resulting in a virtually evolutionary
optimization. It is obviously only attractive to completely replace
an established process by a complete redesign in case of a high
efficiency gain, therefore, often partial steps are subjected to fur-
ther optimization. This work targets one of the steps employed
4generally regarded as safe
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in the partial synthesis of cortisol being a microbial process car-
rying out the 11β-hydroxylation of 11-deoxycortisol. Hence, the
reason why this work focused on biotransformation was that the
manufacturer wished to potentially replace an existing biotrans-
formation step and required the use of existing equipment.
In light of heterologous expression techniques, a possible re-
placement of the existing microbial process may be the use of a
genetically modified organism that is able to carry out the desired
reaction more efficiently. This approach would elegantly circum-
vent the tedious screening for organisms that possess a natural
11β-hydroxylase. Despite a remarkable body of work carried out
using expressed human CYP11B1 and CYP11B2 in mammalian
cell culture systems (Bureik et al., 2002a), only few hosts were
available at the time this work was initiated that would lend
themselves for industrial processes.
A promising step was, however, reported by Dumas et al.
(1996) who transformed a baker’s yeast strain with genetic ele-
ments carrying the cDNAs of the bovine CYP11B1 and its redox
partner Adx. This genetic operation rendered the yeast strain
capable of performing 11β-hydroxylation of 11-deoxycortisol and
11-deoxycorticosterone. Some key points worth noting are that
the authors replaced the native targeting signal of the P450 by
the yeast’s COXVI signal while the coexpresion of adrenodoxin
was found to be crucial for the detection of CYP11B1 activity.
1.5.2 Use of human P450s and fission yeast
Reviewing the sequencing status of genomes5 reveals that none of
the industrially used microorganisms (Streptomyces fradiae, Cun-
ninghamella blakesleeana, and Curvularia lunata) used in the par-
tial synthesis of cortisol was sequenced in 2001. A consequence
5http://www.genomenewsnetwork.org/resources/sequenced genomes/genome guide
index.shtml
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of lacking sequence knowledge is that the naturally occurring
11β-hydroxylases of the mentioned organisms cannot be easily
exploited because the unknown cDNA sequence of the responsi-
ble enzyme cannot be accessed by homology searches. Moreover,
overexpression in the natural host is equally inaccessible due to
non-existent molecular biology tools. One must assume that con-
trolling expression, activity, and hence, the efficiency of the con-
version reaction is restricted to classical bioprocess optimization
techniques applied to the natural host. To circumvent the need
to employ such laborious methods, this work focuses on the use of
recombinant fission yeast strains expressing P450 species known
to perform the required reactions.
Fission yeast is a single-celled free-living organism belonging
to the phylum of sac fungi (Tab. 1.1) with common features
like fungal-type cell wall, closed mitosis, ascus-type sporangium,
ascomycetes-like mode of sex determination and others. Yeasts in
a broader sense are a diverse group of organisms and, for instance,
baker’s yeast belongs to the subphylum Saccharomycotina while
fission yeast to the subphylum Taphrinomycotina. During the ad-
vent of DNA sequencing it became clear that fission yeast could
be classified as equally distant from mammalia as from Saccharo-
myces cerevisiae (Sipiczki, 1995; Wood et al., 2002). The determi-
nation of the divergency point between the subphylums of Saccha-
Table 1.1: Taxonomy of fission yeast
Taxon Name
kingdom Fungi
phylum Ascomycota
subphylum Taphrinomycotina
class Schizosaccharomycetes
order Schizosaccharomycetales
family Schizosaccharomycetaceae
genus Schizosaccharomyces
species Schizosaccharomyces pombe
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romyces (Saccharomycotina) and Schizosaccharomces (Taphrino-
mycotina) is somewhat vague due to missing sequences from cer-
tain member species in the Taphrinomycotina (Sipiczki, 2000).
Therefore, the separation of fission and baker’s yeast must have
occurred between more than 300 million years (Sipiczki, 2000)
and nearly one billion years ago (Heckman et al., 2001; Hedges,
2002), while the separation of fission yeast from Metazoa and
plants took place around 1.6 billion years ago (Heckman et al.,
2001; Wood et al., 2002).
Concerning cell cycle (Russell and Nurse, 1986), RNAi-silenc-
ing (White and Allshire, 2008), centromere organization and con-
trol (Allshire and Karpen, 2008), splicing machinery (Kaufer and
Potashkin, 2000), RNA polymerase III (Huang and Maraia, 2001),
transcription (Remacle et al., 1997), protein kinases (Bimbo et al.,
2005), and many other cellular processes and structures, fission
yeast shows more similarity to higher eukaryotes than baker’s
yeast. That does not necessarily mean that fission yeast is evo-
lutionary closer to mammals but that there is a chance that
some cellular features will be closer to mammals than in other
yeasts. Fission yeast also shows a more mammalian-like post-
translational modification pattern and was successfully used for
the heterologous production of proteins in a considerable number
of studies (Giga-Hama and Kumagai, 1997). Moreover, the ex-
pression of microsomal P450s was demonstrated in three articles
using members of the CYP2C-subfamily (Yamazaki et al., 1993;
Yasumori et al., 1999; Takanashi et al., 2000), albeit for in vitro
studies. With a fully sequenced genome (Wood et al., 2002) that
was already available online in 2001 and well established meth-
ods (Forsburg and Rhind, 2006), fission yeast offers good access
to molecular biotechnology. Additionally, culturing and fermen-
tation techniques might be easily implemented due to its yeast
nature and do not have to be designed from scratch. An addi-
tional benefit of fission yeast might also be the low endogenous
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P450 background of comprising only two species (Wood et al.,
2002), CYP51 (sterol 14α-demethylase) and CYP61 (sterol ∆22-
desaturase). Noteworthy, baker’s yeast possesses an additional
P450 that resembles the Aspergillus nidulans CYP56B1 (Goffeau
et al., 1996).
However, one of the most influential factors that led to the
use of fission yeast in this work was the successful functional ex-
pression of human CYP11B2, a very close relative of the cortisol-
producing CYP11B1, in fission yeast (Bureik et al., 2002b). Here-
by, several key factors could be identified that evaluated fission
yeast as a suitable host for the heterologous expression of human
CYP11B1. First, Western blot development of DISC-SDS-PAGE-
separated protein lysates isolated from mitochondria indicated
correct targeting of the native CYP11B2. In this way, it could be
presumed from the Western band pattern that the targeting se-
quence could be partially processed by the host. The second and
more important point was the evidence for the 11β-hydroxylase
activity of CYP11B2 towards both 11-deoxycorticosterone and
11-deoxycortisol. Third, a fission yeast electron transfer protein
called Etp1 was identified in this study that rendered the human
CYP11B2 activity self-sufficient. Additionally, the coexpression
of the human CYP11B1 and Etp1 led to an increased conversion
rate. In contrast, Adx coexpression was crucial in baker’s yeast
in order to record significant bovine CYP11B1 activities (Dumas
et al., 1996).
As shown in Figure 1.5, the human CYP11B1 is located in
mitochondria of adrenal cortex cells (Fig. 1.4) and catalyzes the
conversion 11-deoxycortisol to cortisol as well as the conversion
of 11-deoxycorticosterone to corticosterone (Bureik et al., 2002a).
The human CYP11B1 and CYP11B2 are very similar enzymes
sharing 95 % identity. Both are synthesized as 503 aa long pre-
cursors including the 24 aa long mitochondrial targeting sequence
which is excised upon translocation to the inner mitochondrial
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membrane (Bureik et al., 2002a). Human CYP11B1 is only func-
tional when being part of a class I electron transfer system com-
prising of AdR and the Fe2S2-ferredoxin Adx (Hannemann et al.,
2007). At the time this work was initiated, the human CYP11B1
was functionally expressed only in mammalian cell lines like CHO,
COS-7, and V79 (Denner et al., 1995a,b) while the heterologous
expression of rat CYP11B1 in Escherichia coli resulted in very
low yields (Nonaka et al., 1998).
The ability of the fission yeast to serve as a host for the expres-
sion of recombinant human P450s was further examined in this
work by including the expression of two microsomal, steroido-
genic P450s. The human CYP21A1 catalyzes the immediate
upstream reactions leading to the substrates of CYP11B1 and
CYP11B2 (see Fig. 1.5). The human CYP17A1 reactions are
more complex. First, it can hydroxylate the C-17 of either pro-
gesterone or pregnenolone to yield 17α-hydroxyprogesterone and
17α-hydroxypregnenolone, respectively (see Fig. 1.5). Further-
more, both 17-hydroxylated steroids can be subjected to a carbon-
carbon bond cleavage between C-17 and C-20 which is catalyzed
by the CYP17A1 via a mechanism that is similar to the CYP19A1
reaction (Ahmed and Owen, 1998). However, the human form of
CYP17A1 is known to efficiently carry out bond cleavage mainly
on ∆5-steroids (Miller, 2005).
The successful heterologous expression of the human CYP11B2
(Bureik et al., 2002a) and the previously shown functional expres-
sion of human microsomal P450s in fission yeast (Yamazaki et al.,
1993; Yasumori et al., 1999; Takanashi et al., 2000) not only jus-
tified the use of fission yeast as a host but also the use of human
enzymes as catalysts. In fact, it is the combination of fission yeast
and human P450s that pointed towards a successful system.
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1.6 Aims of this work
The main objective of this work was the construction of a func-
tional human CYP11B1 expressing fission yeast strain and the
phenotypic enhancement of the 11β-hydroxylase activity on a lab-
oratory scale. Since at the start of this work only a combination of
thin-layer chromatography-based analytics using radioactive sub-
strates was available, the development of suitable HPLC-based
analysis methods was also required. Furthermore, as a prepa-
ration for the coexpression of further components of the class I
electron transfer system used by CYP11B1 (see reaction system
1.2), the setup of a suitable whole-cell biotransformation assay
format and the comparison of recombinant fission yeast strains
expressing different CYP11B1 variants was intended. To test
fission yeast’s ability to carry out whole-cell biotransformations
when used as a host for human microsomal P450s, the study
was extended to functionally express the human CYP17A1 and
CYP21A1, to develop suitable analytical methods, and to setup
a suitable laboratory-scale biotransformation assay for the par-
ticular activities.
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Discussion
2.1 Functional expression of human CYP11B1
in fission yeast
Within the context of this work, some preliminary studies were
conducted on the expression of a human CYP11B1 variant that
showed three amino acid mutations compared to the previously
published sequence (Mornet et al., 1989). The F494C substitu-
tion was described by Kawamoto et al. (1990) while the L52M and
the I78V substitutions by Denner et al. (1995a,b); Bo¨ttner et al.
(1996, 1998); Cao and Bernhardt (1999); Bechtel et al. (2002).
Later on, the mentioned positions within the human CYP11B1
were substituted by the originally described amino acids (Mor-
net et al., 1989; Kawamoto et al., 1990) resulting in four hu-
man CYP11B1 expressers (see Hakki et al. (2008) and Tab. 2.1).
Additionally, Table 2.1 also shows the used parent strains, the
CYP11B2 expressor MB164, and both microsomal P450 expres-
sors.
28
PhD thesis–Ca˘lin-Aurel Dra˘gan Section 2.1
Table 2.1: Fission yeast strains used in this work.
Strain Genotype CYP11B1 variant Reference
MB1631 h- ura4-D18 none NCYC
MB175 h- ade6-M210 leu1-32 ura4-D18 his3-∆1 none Burke and Gould (1994)
MB164 h- ura4-D18 leu1::pCAD1-CYP11B1 hCYP11B2 Bureik et al. (2002b)
SZ1 h- ura4-D18 leu1::pCAD1-CYP11B1 hCYP11B1 Dragan et al. (2005)
SZ522 h- ura4-D18 leu1::pCAD1-CYP11B1I78V hCYP11B1
I78V Hakki et al. (2008)
SZ783 h- ura4-D18 leu1::pCAD1-CYP11B1L52M hCYP11B1
L52M Hakki et al. (2008)
CAD1 h- ura4-D18 leu1::pCAD1-CYP11B1L52MI78V hCYP11B1
L52MI78V Bureik et al. (2004)
CAD8 h- ade6-M210 leu1-32 ura4-D18 his3-∆1 pNMT1-hCYP17 hCYP17A1 Dragan et al. (2006b)
CAD18 h- ade6-M210 leu1-32 ura4-D18 his3-∆1 pNMT1-hCYP21 hCYP21A1 Dragan et al. (2006a)
1: NCYC2036
2: originally named SZM52L
3: originally named SZ1V78I
2.1.1 The human CYP11B1 is expressed and correctly
localized in fission yeast cells
The pINT5 derivate, pCAD1, was successfully used to integrate
the Pnmt1-hCYP11B1 expression cassette into the leu1 locus on
chromosome II of parent strain NCYC2036. All hCYP11B1 pro-
teins were expressed as fusion proteins with a C-terminal his6
followed by a Pk-tag (Dragan et al., 2005). After identifying cor-
rect integrands by replica plating onto EMM medium containing
phloxine but lacking leucine, clones were chosen for further char-
acterization. Under fully induced expression conditions, the con-
structed strains CAD1, SZ52, SZ78, and SZ1 showed a wildtype-
like phenotype and a significantly slower growth when compared
to the parent strain NCYC2036 (data not shown). The slower
growth kinetics was also observed with the hCYP11B2 expres-
sor MB164 (Bureik et al., 2002b) and might be interpreted as a
consequence of mitochondrial P450 overexpression.
The theoretical average mass of the expressed CYP11B1 is
composed of the mature 55 kDa stemming from the structural
part plus the 2 kDa stemming from the fused his6 and Pk-tags
yielding 57 kDa. Denaturing DISC-SDS-PAGE of mitochondrial
lysates of the respective strains combined with α-Pk/α-rabbit
antibody-based Western detection of tagged proteins revealed a
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signal with a molecular mass between 48 kDa and 62 kDa for both
hCYP11B1
L52MI78V (not shown) and hCYP11B1 (Dragan et al.,
2005). The apparent molecular masses of both CYP11B1 vari-
ants were hence in agreement with the above calculated mass
and also with published data on hCYP11B1 expression in COS-1
cells (Bo¨ttner et al., 1998) and expression of the 98 % identical
hCYP11B2 in fission yeast (Bureik et al., 2002b).
Obviously, similar to the expression of CYP11B2, the native
CYP11B1 presequence could correctly target the protein to the
fission yeast mitochondria irrespective of the CYP11B1 variant.
Since no additional signals were observed in the gel lanes con-
taining the separated mitochondrial proteins following Western
blot analysis (hCYP11B1
L52MI78V analysis not shown, hCYP11B1
analysis in Dragan et al. (2005)), post-translational processing of
the CYP11B1 variants seemed to be terminated at the time of
cell disruption. Remarkably, this complete processing could not
be observed in mitochondrial lysates of the CYP11B2 expressor
MB164 (Bureik et al., 2002b).
2.1.2 Fission yeast strains expressing the human en-
zyme CYP11B1 convert 11-deoxycortisol to cor-
tisol in vivo
The initial 11-deoxycortisol biotransformations were performed
with the hCYP11B1
L52MI78V expressor CAD1 and analyzed using
thin-layer chromatography (TLC) as well as high-pressure liq-
uid chromatography (HPLC) revealing the formation of a specific
product in CAD1 samples (data not shown). The TLC analy-
sis of the 11-deoxycortisol biotransformation showed a product
that migrated at the same distance as the cortisol reference. Ad-
ditionally, the use of 3H-labeled 11-deoxycortisol as a substrate
confirmed the presence of the radioactive signal within the spot
of the product in TLC analysis combined with autoradiography
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(Bureik et al., 2004). These results were confirmed by HPLC
analysis where the formation of a compound was observed that
showed the same retention time and the same spectroscopic prop-
erties determined by a diode array detector (DAD) as the cortisol
reference (not shown). Thus, the detected product was specific
to the biotransformation by CAD1 and was not present in sam-
ples stemming from the parent strain NCYC2036. After perform-
ing site-directed mutagenesis on the hCYP11B1
L52MI78V cDNA
sequence to yield hCYP11B1, the initial results obtained using
strain CAD1 could be confirmed by strain SZ1 with both meth-
ods TLC combined with autoradiography (Dragan et al., 2005)
as well as HPLC (not shown). Taken together, the results men-
tioned in this paragraph demonstrated the successful biotrans-
formation of 11-deoxycortisol to cortisol by fission yeast strains
expressing hCYP11B1. The significant activity of the recombi-
nant fission yeast strains demonstrated that the presence of the
C-terminal his6 and the Pk-tag consisting of 16 additional amino
acids did neither abolish substrate binding nor electron transfer
to the P450.
The analysis of the biotransformation samples revealed the
presence of a byproduct derived from 11-deoxycortisol that could
be readily detected by TLC analysis using visual fluorescence
quenching, autoradiography, and HPLC analysis (data not shown).
This byproduct appeared in samples of strain CAD1, SZ1, and
the parent strain NCYC2036, indicating a potential side reaction
taking place in the host. One explanation for the appearance of
the byproducts is the loss of the C-4,C-3-enone group of the 11-
deoxycortisol’s A-ring which could be, in principle, catalyzed by
the previously described ∆4-reductase combined with a 3α-HSD
activity (Pajic et al., 1999). However, this pathway seems im-
probable since it would rather lead to a significant absorption
shift towards lower wavelengths due to the ketone group still
present at C-20. A more probable explanation for the presence
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of a byproduct might be the endogenous 20α-HSD activity (Pajic
et al., 1999). Albeit the 20α-HSD activity of fission yeast was
demonstrated using progesterone and 20α-hydroxyprogesterone,
reduction of other 20-oxo-steroids cannot be ruled out. A possible
activity towards the C-20,C-17-ketol group is, for instance, sup-
ported by reports where a bacterial (Krafft and Hylemon, 1989)
and a mammalian 20α-HSD (Sato et al., 1972) are indeed able
to reduce the keto group at C-20 of 11-deoxycortisol and 17α-
hydroxyprogesterone, respectively.
2.1.3 Space-time yield on cortisol
As mentioned in the introduction, one intention of this study was
to elucidate possible replacements of actual industrial steroid bio-
processes. Hence, in order to better assess the ability of the de-
veloped systems, the parameter space-time yield (〈CR 〉) given in
µM d−1, which is usually used in reactor process engineering, was
applied to the analysis of steroid bioconversion data. There are
different ways of calculating the space-time yield. One possibility
is to determine the product concentration c(t) at a given time t,
usually given in days, and then to calculate
〈CR 〉 =
c(t)
t
. (2.1)
However, since the formation rate of cortisol and other steroidal
products was not constant during the biotransformation period as
observed in this work, the space-time yield between consecutive
sampling times defined as
〈CR 〉t∗,t =
ct − ct∗
t− t∗
(2.2)
with t, t∗ in days and t > t∗ was also used. The 〈CR 〉-function
can be identified as the first derivative of c(t) for t − t∗ → 0.
As might be presumed when regarding the unit of 〈CR 〉, no nor-
malization to biomass-related parameters was made yielding a
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parameter that is highly dependent on the biotransformation con-
ditions. Therefore, a set of biotransformation conditions was set
as standard conditions consisting of a biotransformation period
of 72 h, a cell suspension volume of 10 mL, a substrate concen-
tration of 1 mM added from a 40 mM ethanolic stock solution,
an incubation temperature of 30 ◦C, an agitation of 300 rpm, and
a terminal HPLC analysis.
The average space-time yield on cortisol over a 72 h biotrans-
formation period (〈CR 〉0,3) for the hCYP11B1
L52MI78V expressor
CAD1 under standard conditions was 9.6 ± 0.4 µM d−1, while
SZ52 showed 6.7 ± 0.5 µM d−1, SZ78 47 ± 3 µM d−1, and SZ1
55 ± 3 µM d−1(not shown). Thereby, the kinetics of the cortisol
formation was nearly linear until t = 48 h where a slight rate
decrease occurred (not shown). These data demonstrated the
significant adverse effect of the I78V mutation within CYP11B1.
The resulting activity relation between the fission yeast strains
expressing different hCYP11B1 variants could be confirmed in an
assay using 100 µM 11-deoxycortisol (Hakki et al., 2008). Ac-
cording to a three-dimensional homology model of hCYP11B1,
the amino acid residue at the position 52 lies at the surface of the
enzyme and hence, is regarded as a minor influence when sub-
jected to substitution. In contrast, position 78 is located near
the substrate binding site and is expected to exert more influence
on activity (Hakki et al., 2008). This theoretical thoughts should
be regarded with caution due to the numerous approximations
made during the generation of a homology model. The only valid
statement that can be made on firm ground to date is that the
78 position was unexpected to play such a role in activity.
The dependence of 〈CR 〉 on the biotransformation conditions
can be readily seen when regarding the results of Appel et al.
(2005) where a rate of approximately 100 µM d−1 was deter-
mined using a growing CAD1 culture and HPLC analysis. More-
over, using concentrated cell suspensions of strain SZ1 express-
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ing hCYP11B1 and 5 mM 11-deoxycortisol concentrations yielded
space-time yields of 200 µM d−1 as analyzed by TLC (Dragan
et al., 2005). In contrast, the yield on cortisol using the bovine
CYP11B1 expressed in baker’s yeast was less than 2 % of a
100 mg L−1 (approximately 290 µM) initial concentration (Du-
mas et al., 1996), which translates to roughly 5.8 µM of cortisol.
This amount was measured in a cell suspension growing from
2 × 107 cells mL−1 to 6 × 108 cells mL−1 during a 72 h incuba-
tion period yielding 〈CR 〉0,3 = 1.9 µM d
−1. Thus, the 〈CR 〉0,3
value of SZ1 measured under standard conditions was at least
28 times higher. Apparently, the presence of Adx and AdR was
essential in baker’s yeast in order to reach a space-time yield of
about 12 µM d−1 under the described conditions (Dumas et al.,
1996). Nevertheless, the baker’s yeast figure is still more than 4.5
times and 16 times lower when compared to SZ1 under standard
(not shown) and optimized conditions (Dragan et al., 2005). Re-
markably, this was achieved in absence of Adx coexpression using
a roughly three times lower cell density than used with baker’s
yeast.1 Of course, the reason for the differences between fission
and baker’s yeast are difficult to explain due to the complex ex-
perimental and physiological differences between the two systems.
Whether fission yeast might be evolutionary less derived than
baker’s and hence, would offer a more convenient cellular envi-
ronment for the expression of human CYP11B1 will be addressed
in the next section.
2.1.4 Fission yeast electronically sustains mitochondrial
P450 reactions
Obviously, in fission yeast the expressed hCYP11B1 species could
couple to an endogenous electron transfer, as was expected from
previous findings reported by Bureik et al. (2002b). However,
1Assuming linear growth during the bioconversion period of baker’s yeast.
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the presence of an electron transfer chain serving human, mito-
chondrial P450s seemed peculiar in an organism whose lineage
departed from the main mammalian branch around 1.6 billion
years ago (Heckman et al., 2001; Wood et al., 2002) and even
more so in absence of an endogenous mitochondrial P450. For-
tunately, past and recent work significantly contributed to the
elucidation of the electron transfer chain’s nature.
The mitochondrially localized ferredoxin Etp1 was presented
as a candidate with a high probability of playing the role of
Adx based on protein sequence homology, preliminary electron
transfer experiments, and overexpression studies performed in fis-
sion yeast (Bureik et al., 2002b). Later on, further experimental
data demonstrated that electron transfer on bovine CYP11B1
could be sustained by this protein (Schiﬄer et al., 2004; Ewen
et al., 2008). Moreover, the existence of a putative Etp1 reduc-
tase (SPBC3B8.01c, Arh1) was also first postulated by Bureik
et al. (2002b) and later on experimentally characterized and con-
firmed by Ewen et al. (2008). The statistical analysis of the fission
yeast Arh1 protein sequence revealed a much higher identity to
bovine and human AdR than to the Arh1 sequence of baker’s
yeast (Ewen et al., 2008). Including the results of the mentioned
studies, the putative redox system responsible for the observed
11β-hydroxylase activity in fission yeast strains expressing hu-
man, mitochondrial CYP11B1 can be described by:


Arh1ox +NADPH+H
+ −−→ Arh1red +NADP
+
Arh1red + 2Etp1ox −−→ Arh1ox + 2Etp1red
hCYP11B1ox + S −−⇀↽− [hCYP11B1ox·S]
2Etp1red + [hCYP11B1ox·S] + O2 + 2H
+ −−→ 2Etp1ox + hCYP11B1ox + P+H2O


.
(2.3)
At least in baker’s yeast, it could be shown that mitochondrial
ferredoxin and ferredoxin reductase participate in heme biosyn-
thesis (Barros et al., 2002) which might also be the native func-
tions of Arh1 and Etp1 in fission yeast. Consequently, since ad-
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ditional electron sinks cannot be ruled out, host-related electron
sinks must be considered according to


endogenous proteins
NADPH // Arh1 //
?
66
n
n
n
n
n
n
n
n
n
n
n
n
n
Etp1 //
?
OO
hCYP11B1 // S


(2.4)
by use of the vectorial electron flow symbolism. These findings
imply that the ability to transfer electrons from NADPH to a
mitochondrially localized P450 might have evolved before and
independent of the presence of the terminal P450. As mentioned
above, the ramification of the fission yeast and the mammalian
lineages occurred more than 1 billion years ago but fission yeast
seemed to retain more mammalian-like structures and processes
than the more derived baker’s yeast (Sipiczki, 2000). This could
explain why in baker’s yeast the presence of bAdx was crucial
in order to yield detectable bCYP11B1 activity (Dumas et al.,
1996) while in fission yeast the endogenous systems were able to
sustain hCYP11B1 activity. However, since bCYP11B1 was not
expressed in fission yeast, it cannot be ruled out that hCYP11B1
cooperates more efficient with Etp1 than bCYP11B1.
2.1.5 The human CYP11B1 and CYP11B2 show differ-
ent kinetic properties when expressed in fission
yeast
Since the nearly identical fission yeast strains MB164 (expresses
hCYP11B2) and SZ1 (expresses hCYP11B1) were available, it was
interesting to compare the in vivo activities of the expressed en-
zymes. Due to the previous studies using the mutated form of
hCYP11B1 (Denner et al., 1995a,b; Bo¨ttner et al., 1996, 1998; Cao
and Bernhardt, 1999; Bechtel et al., 2002), the activity compari-
son included also the hCYP11B1
L52MI78V expressing fission strain
CAD1.
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When assayed under standard conditions, strain MB164 ex-
pressing hCYP11B2 showed a nearly 8 and 60 times lower space-
time yield on cortisol (〈CR 〉0,1 = 1 ± 0.6 µM d
−1, not shown)
when compared to the value of strain CAD1 (〈CR 〉0,1 = 7.8 ±
0.6 µM d−1, not shown) and strain SZ1 (〈CR 〉0,1 = 60±3 µM d
−1,
not shown), respectively. Regarding the overall 72 h biotransfor-
mation period, the space-time yield of MB164 was still slightly
more than 3 times and 18 times lower than for CAD1 and SZ1.
These relations are more or less consistent with the approxi-
mately twenty times higher 11-deoxycortisol conversion rate of
hCYP11B1
I78V compared to hCYP11B2 when expressed in COS-
1 cells (Bo¨ttner et al., 1996). Although being described as the
preferred substrate, the measured space-time yield of MB164 on
corticosterone during the initial 24 h biotransformation period
(〈CR 〉0,1 = 0.9±0.4 µM d
−1, not shown) was 30 times lower than
for SZ1 (〈CR 〉0,1 = 30±2 µM d
−1, not shown) while for the aver-
age space-time yield (〈CR 〉0,3) this ratio reduced to 18 (data not
shown). No values were gained for the 11-deoxycorticosterone bio-
transformation by CAD1. The observed reduction in the 〈CR 〉0,3
ratio between MB164 and SZ1 for both substrates 11-deoxycor-
ticosterone and 11-deoxycortisol was phenomenologically caused
by the four-fold activity increase of MB164 during the last 48 h of
biotransformation when compared to the initial 24 h. In contrast,
the SZ1 activity was more or less constant throughout the whole
biotransformation period.
Peculiarly, during IC50 determination studies, MB164 could
convert approximately 20 % of 100 nM 11-deoxycorticosterone
within a period of 8 h (Bureik et al., 2004) while CAD1 needed
24 h to achieve similar results with 11-deoxycortisol (not shown).
This means that under relatively low substrate concentrations
the turnover of hCYP11B2 was higher than the turnover shown
by hCYP11B1
L52MI78V.
These apparently contradictory results could be resolved by
37
PhD thesis–Ca˘lin-Aurel Dra˘gan Section 2.1
enzyme kinetics alone. If conversion velocities of the CYP11B1
and CYP11B2 systems would be described by pseudo-Michaelis-
Menten kinetics dependent on the substrate concentration, the
activity differences observed in this work and by Bo¨ttner et al.
(1996) could be easily explained if
K1/2(CYP11B1) > K1/2(CYP11B2, ) (2.5)
vmax(CYP11B1) > vmax(CYP11B2) (2.6)
would hold. This, in turn, implies the existence of a specific
substrate concentration c∗ which relates to the assayed substrate
concentration cS as
cS


< c∗ ⇒ v(CYP11B1) < v(CYP11B2),
= c∗ ⇒ v(CYP11B1) = v(CYP11B2),
> c∗ ⇒ v(CYP11B1) > v(CYP11B2).
(2.7)
Bo¨ttner et al. (1996) reported previously that the conversion rates
of CYP11B1 and CYP11B2 could not be kinetically distinguished
at an initial 11-deoxycortisol concentration of 250 nM but first
at 5 µM. Thus, the presumed substrate concentration c∗ at
which turnover identity would hold between hCYP11B1
L52MI78V
and hCYP11B2 might have been near the reported 250 nM in
COS-1 cells. Later on, for the case cS > c
∗ the correctness of
the above relations could be demonstrated in a direct comparison
between MB164 and SZ1 using substrate concentrations between
10 µM to 1 mM (data not shown). However, different kinetic pa-
rameters of the P450s were surely not the only factors that could
contribute to conversion rate differences between CYP11B1 and
CYP11B2.
For instance, the efficiency of the presequence targeting and
processing upon mitochondrial import might be different between
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the two enzymes. Actually, no direct and systematic comparison
was made to address this.
The C-terminal tags fused to the CYP11Bs present another
difference. A his6 followed by a Pk-tag were fused to all ex-
pressed CYP11B1 variants while solely a his6 tag was fused to
the CYP11B2 expressed by MB164 (Bureik et al., 2002b). At
least in E. coli, a C-terminal his6 tag was described as advan-
tageous concerning proteolytic degradation of expressed human
enzymes (Nonaka et al., 1998). However, whether the presence
of the additional C-terminal Pk-tag might be beneficial for the
CYP11B1 variants remains uncertain.
Electron delivery by the host seems to be guaranteed for both
enzymes but the specific electron transfer rates might differ. Ac-
cording to Equation 2.3, the operative interaction between the
host and the expressed enzymes has to take place between Etp1
and the P450s. The share of this interaction to the macroscopi-
cally measured space-time yield might only be assessed using in
vitro systems.
The expression of CYP11B1 and CYP11B2 differentially af-
fected the growth of the host. While the growth rate constant of
MB164 was nearly three-fold lower compared to the parent strain,
CAD1 showed an only two-fold lower figure (data not shown).
This might be a sign of more deleterious physiologic effects caused
by hCYP11B2 compared to hCYP11B1 that might explain the ob-
served biotransformation differences between MB164, and CAD1
or SZ1.
Eventually, it should be kept in mind that the saturation con-
centration of 11-deoxycorticosterone is around 100 µM in EMM
while the value for 11-deoxycortisol is one order of magnitude
higher (data not shown). Although Equation 2.5 and Equation
2.7 will not lose their validity per se, the portion of the rela-
tion describing the kinetics for substrate concentration greater
than 100 µM will be heavily influenced by the different solubility
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of the substrates. Indeed, steroid solubility would offer an even
simpler explanation for the observed effects. Consequently, the
space-time yield values obtained using 1 mM substrate concen-
trations will include the solubility effect and might not be linked
to any of the above mentioned factors.
2.1.6 Application of CYP11B1 expressing fission yeast
strains for inhibition studies
Strain CAD1 was used during the discovery process of selective
CYP11B1 inhibitors as part of an already existing assay design
(Bureik et al., 2004) which was further developed during this
work. Most of the discussion dealing with the applicability of
fission yeast strains expressing human mitochondrial P450s for
the discovery of selective CYP11B1 and CYP11B2 inhibitors was
already dealt with by Bureik et al. (2004). The facts that will be
stressed here will focus more on the technical side of the system’s
development.
During the 24 h incubation period of strain CAD1, a passive
gas exchange pathway between cell suspension and atmosphere
was required in order to obtain measurable conversion rates. This
could be achieved in a very simple way by modifying conventional
1.5 mL tubes (Fig. 2.1). Since conical 200 µL pipette tips were
used to assure gas exchange, their lengths determined the diam-
eter of the pathway and hence, also the flow resistance. As could
be demonstrated, the length of the gas exchange pathway exerted
considerable control over the reaction rate (data not shown). At
the first glance the successful application of the tip-tubes might
appear self-evident because oxygen appears as an educt in the
CYP11B1 reaction (Eq. 1.2). However, a more important param-
eter is the oxygen consumption rate of the host which leads to
rapid depletion of the dissolved oxygen as was shown with con-
siderable lower cell density suspensions of strain MB175 (Dragan
40
PhD thesis–Ca˘lin-Aurel Dra˘gan Section 2.2
Figure 2.1: Modification of a 1.5 mL tube to yield a tip-tube. The exhaust channel is made
by piercing the cap of a 1.5 mL reaction tube with a 200 µL pipette tip (A). To avoid plastic
material blocking the air pathway, the pipette tip was cut at the indicated line (B) to finally
yield a tip-tube (C).
et al., 2006a). Consequently, a potential oxygen competition be-
tween host and recombinant processes might arise that could be
effectively prevented using tip-tubes. Another important factor
observed during the incubation was that gas exchange pathways
were extremely beneficial for the dissipation of pressure built up
in the previously tightly closed tubes by carbon dioxide evolution.
2.2 Functional expression of the microsomal
human P450s CYP17A1 and CYP21A1 in
fission yeast
2.2.1 Expression of microsomal P450s
Transformation of fission yeast strain MB175 with the plasmids
pNMT1-hCYP17 and pNMT1-hCYP21 resulted in the new strains
CAD8 and CAD18 (see Tab. 2.1). The new strains grew signif-
icantly slower then the parent strain MB175 but did not show
any phenotypic alterations (data not shown). Protein extraction
samples gained after inducing protein expression in absence of thi-
amine showed specific signals when probed with an α-Pk antibody
that were not present in the protein samples of the parent strain
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(Dragan et al., 2006a,b). The apparent molecular masses of the
signals were found to be in good agreement with the theoretically
calculated masses of the tagged proteins being 59 kDa and 58 kDa
for the hCYP17A1 and the hCYP21A1, respectively. Moreover,
a good agreement regarding the hCYP17A1 molecular mass was
also observed when compared to other heterologous expression
systems like E. coli (Imai et al., 1993; Grigoryev et al., 1999),
baker’s yeast (Auchus et al., 1998), and Pichia pastoris (Kolar
et al., 2007). Similar results were observed for the hCYP21A1
molecular mass when expressed in COS-1 cells (Tusie-Luna et al.,
1990), E. coli (Hsu et al., 1999), and baker’s yeast (Hsu et al.,
1996).
When regarding the gel lane loaded with CAD8 cell lysate, a
distinctive band pattern that specifically reacted with the α-Pk
antibody was detected. Since no similar signals were observed in
the lane loaded with cell lysate stemming from the parent strain,
it can be concluded that the fragments showing lower apparent
molecular masses than 59 kDa were C-terminal fragments de-
rived from the expressed hCYP17A1. Although very often the
Western analysis was not shown in research articles using het-
erologous hCYP17A1 expression while others paid little attention
to the fact, similar electrophoretic findings were often observed
in bacterial (Imai et al., 1993), baker’s yeast (Auchus et al., 1998;
Gupta et al., 2001; Costa-Santos et al., 2004), and Pichia pastoris
(Kolar et al., 2007) lysates. The observed degradation behavior of
hCYP17 is worth noting since it apparently took place in various
heterologous expression systems.
2.2.2 Human CYP17A1 and CYP21A1 are functionally
expressed in fission yeast
The recombinant fission yeast strain CAD8 expressing hCYP17A1
converts progesterone to 17α-hydroxyprogesterone and to 16α-
42
PhD thesis–Ca˘lin-Aurel Dra˘gan Section 2.2
hydroxyprogesterone as well as pregnenolone to 17α-hydroxy-
pregnenolone (Dragan et al., 2006b). The steroid 16α-hydroxy-
progesterone could not be detected in HPLC chromatograms of
cholesterol oxidase-treated pregnenolone bioconversion samples,
suggesting no hydroxylation of pregnenolone at C-16. More-
over, no androstenedione signal was observed in any sample re-
gardless whether oxidase treatment was involved or not, which
strongly points towards a missing 17,20-lyase activity. The mea-
sured space-time-yields for the first 24 h of biotransformation
were calculated as 〈CR 〉0,1 = 176 ± 13 µM d
−1 and 〈CR 〉0,1 =
83 ± 9 µM d−1 for 17α-hydroxyprogesterone and 16α-hydroxy-
progesterone, respectively (Dragan et al., 2006b). Thereby, the
〈CR 〉-values reached a plateau before t = 72 h.
The observed relative space-time yield magnitudes of the de-
tected products were similar to biotransformation results obtained
using COS-1 cells expressing hCYP17A1 (Swart et al., 1993).
Hitherto, the metabolite 16α-hydroxyprogesterone was regularly
encountered in hCYP17A1 activity assays, for instance when ex-
pressed in E. coli (Ehmer et al., 2000), baker’s yeast (Auchus
et al., 1998), and Pichia pastoris (Kolar et al., 2007). It seems
that this pathway might be physiologically active according to
data gained using fetal adrenal and adult testis microsomes (Swart
et al., 1993). The missing C-16 hydroxylation of pregnenolone was
also in accordance with data gained by Swart et al. (1993).
The 17,20-lyase activity of hCYP17A1 seems to be mainly ex-
erted on 17α-hydroxypregnenolone but not on 17α-hydroxypro-
gesterone (Auchus et al., 1998; Gilep et al., 2003). However,
the use of purified, recombinant hCYP17A1 produced in E. coli
demonstrated a more than 100-fold lower 17,20-lyase activity to-
wards 17α-hydroxypregnenolone compared to the 17-hydroxylase
activity towards pregnenolone (Imai et al., 1993). A relatively
low 17,20-lyase activity towards 17α-hydroxypregnenolone was
also confirmed using JM109 E. coli whole cells expressing solely
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hCYP17A1 (Sagara et al., 1993). Moreover, baker’s yeast micro-
somes containing coexpressed hCYP17A1 and reductase showed a
lower 17,20-lyase activity towards 17α-hydroxyprogesterone com-
pared to the activity towards 17α-hydroxypregnenolone (Auchus
et al., 1998). Common to all mentioned studies where 17,20-lyase
activity was detected was the use of C-17 hydroxylated steroids
as substrates. Since this was not the case in this work, at least
the weak 17,20-lyase activity towards 17α-hydroxypregnenolone
might have been suppressed by pregnenolone being present in ex-
cess.
The direct comparison of the hCYP17A1 metabolite space-
time yields determined in this work and most published studies
was difficult due to the fact that in vitro studies usually report
rates normalized to the P450 content. On the other hand, rates
were often gained under relatively low substrate concentrations
leading to figures far below vmax. One report stated that E. coli
cells expressing bCYP17A1 and rCPR were able to convert 50 µM
progesterone at initial rates of up to 104 µM d−1 (Shet et al.,
1997). However, this remarkable figure could be sustained for only
a relatively short period of 5 min. Moreover, activity in presence
of 200 µM progesterone decreased apparently in an exponential
fashion yielding rates of around 1200 µM d−1 when referred to a
30 min incubation period. Hence, it can be concluded that the E.
coli system could be hardly applied in the large-scale production
of metabolites under the published conditions. More comparable
assay conditions were applied to the conversion of progesterone by
a recombinant baker’s yeast strain expressing bCYP17A1. This
study reported rates around 240 µM d−1 (Degryse et al., 1999),
which were similar to values obtained in this work (Dragan et al.,
2006b).
The fission yeast strain CAD18 was able to convert proges-
terone to 11-deoxycorticosterone and 17α-hydroxyprogesterone to
11-deoxycortisol in vivo (Dragan et al., 2006a). Thereby, the
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measured space-time yields during the first 24 h of the biotrans-
formation period were 〈CR 〉0,1 = 21 ± 1 µM d
−1 and 〈CR 〉0,1 =
259± 9 µM d−1 for 11-deoxycorticosterone and 11-deoxycortisol,
respectively (Dragan et al., 2006a). The later reaction was car-
ried out at a rate roughly one order of magnitude higher than the
former. This finding correlates well with data from reports us-
ing recombinant hCYP21A1 expressed in baker’s yeast, where the
apparent hydroxylation rate of 17α-hydroxyprogesterone was also
considerably higher than that for progesterone (Wu et al., 1991).
The use of bCYP21A1 expressed in COS-1 cells similarly yielded
lower rates for the progesterone conversion (Lorence et al., 1989),
while purified recombinant hCYP21A1 displayed the same prefer-
ences as well (Hsu et al., 1999). Since most authors did not focus
on whole-cell biotransformation, no space-time yield comparison
could be reliably performed. As was the case with studies dealing
with hCYP17A1, most reports in which hCYP21A1 reactions were
measured worked at lower substrate concentrations than used in
this work.
2.2.3 Application of CYP17A1 and CYP21A1 express-
ing fission yeast strains for inhibition studies
Using both CAD8 and CAD18, it was possible to set up an IC50
screening system under similar conditions as used for strain CAD1
or MB164 (Dragan et al., 2006b). As in the case of the mitochon-
drial P450 expressing fission yeast strains, the specific discussion
dealing with the particular inhibitors is dealt with in the article.
It shall be mentioned here, however, that the main result in this
study was to determine that hCYP21A1 should be carefully re-
garded when developing hCYP17A1 inhibitors due to the relative
high resemblance (29 % amino acid identity) between the two en-
zymes. Thus, as could be shown in the study, cross-inhibition of
hCYP21A1 by hCYP17A1 inhibitors cannot be ruled out. Dur-
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ing the assay design phase, a couple of interesting points worth
mentioning surfaced.
First, using relatively low substrate concentrations (100 nM)
revealed that the progesterone conversion rate differences between
hCYP17A1 and hCYP21A1 expressing strains, usually observed
when using 1 mM substrate concentrations, vanished. Similar
to the rate difference explanation given for mitochondrial P450s
(Sec. 2.1.5), it might be presumed that the kinetics are approach-
ing identity under decreasing substrate concentrations. In con-
trast to the mitochondrial P450 expressing strains, however, the
microsomal expressing fission yeast strains were able to convert
25 % to 40 % of the respective substrates within 15 min of assay
time (Dragan et al., 2006b).
Second, frequent sampling revealed the formation of a byprod-
uct. Applying kinetic modeling of the CYP17-system under IC50
assay conditions yielded the theoretical model A as the best fit to
experimental data with 17α-hydroxyprogesterone being the pre-
cursor of the observed byproduct (Dragan et al., 2006b). The
correctness of model A might be supported by a study using
baker’s yeast expressing bCYP17 where 17α-hydroxyprogesterone
was converted by an endogenous 20α-HSD to 17α,20α-dihydroxy-
progesterone (Shkumatov et al., 2002). Since fission yeast pos-
sesses a 20α-HSD (Pajic et al., 1999), it is highly probable that
the same reaction might take place in fission yeast as well. As
mentioned above (see Sec. 2.1.2), 20α-HSDs from other organisms
were able to reduce the keto group at C-20 of 17α-hydroxypro-
gesterone (Sato et al., 1972; Krafft and Hylemon, 1989), so the
presumed reduction might occur as in baker’s yeast.
Third, it is noticeable that in contrast to the IC50 values ob-
tained using microsomal preparations containing hCYP17A1 the
values measured using the fission yeast system were generally bi-
ased towards higher values (Dragan et al., 2006b). This effect
might be explained by the presence of basic nitrogen containing
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chemical groups in the structures of the tested inhibitors. Their
pH-dependent charge might largely contribute to their ability to
cross the fission yeast’s plasma membrane. Since microsomal as-
says are usually carried out at pH = 7.4, nitrogen group contain-
ing compounds might be significantly present in their uncharged
form while in the acidic fission yeast medium (pH = 5.4) their
ratio might be significantly reduced. Charged compounds hardly
can pass membranes unless suitable transporter systems are at
hand, so the observed differences might be due to pure thermo-
dynamics.
2.2.4 Electronic coupling of microsomal P450s to host
systems and its implications
Since hydroxylated metabolites of hCYP17A1 and hCYP217A1
substrates were readily detected during biotransformation assays,
a viable transfer of electrons to the human enzymes can be as-
sumed to take place in the host. A highly probable primary source
of electrons to the P450s is the endogenous fission yeast CPR ho-
mologue expressed from the ccr1 gene (Wood et al., 2002). Al-
though the host’s putative CPR was found to share more than
30 % identity to higher mammalian CPR sequences and bears cru-
cial flavine coenzyme binding motifs (Miles, 1992), its exact func-
tion was not yet experimentally elucidated. A secondary source
of electrons, at least for the hCYP17A1, might be cytochrome b5.
However, since no 17,20-lyase activity was observed in this work,
the involvement of the host’s cytochrome b5 system including the
cytochrome b5 reductase (CBR) remains questionable.
Often in baker’s yeast and also in fission yeast, growing cells in-
duce sterol and desaturated fatty acids syntheses (Koukkou et al.,
1993) in order to cope with changing environmental conditions
like increasing fermentative ethanol concentrations and hypoxia.
In fission yeast, the transcription of the responsible genes was
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shown to be upregulated in a sterol regulatory element binding
protein (SREBP)-dependent way (Hughes et al., 2005). It is well
known that at several steps in the sterol and fatty acid biosyn-
thetic pathway redox reactions are involved that require electron
supply. For instance, the fission yeast squalene monooxygenase
(SMO), the 22-sterol desaturase (CYP61A1) and the sterol 14α-
demethylase (CYP51A1) depend on reduction equivalents sup-
plied by the CPR of which Rosenfeld et al. (2002) reported that
it might be a considerable source of reactive oxygen species (ROS)
in baker’s yeast. Already more than 40 years ago, data gained
with fission yeast demonstrated the existence of a non-respiratory
oxygen consumption not linked to glucose consumption (Heslot
et al., 1970) which apparently seems to confirm the data published
by Rosenfeld et al. (2002).
The expression of microsomal P450s by strains CAD8 and
CAD18 led to significantly lowered growth rate constants when
compared to the wildtype strain MB175 (data not shown). This
observation was assumed to be correlated to the fully induced
expression state of Pnmt1. As a possible consequence it could
be suspected that overexpressed functional P450s are compet-
ing for electrons in the host’s cellular environment and, there-
fore, are representing an additional electron sink that interferes
with the above mentioned sterol biosynthesis pathway leading to
growth retardation. At the same time, this competition might
phenomenologically lead to reduced oxygen consumption due to
the reduced loss of electrons by the host’s CPR. Oxygen mea-
surements as well as ROS generation data gained in this work
seems to point towards a view where the presence of substrate
significantly reduces oxygen consumption and ROS generation in
both strains CAD8 (data not shown) and CAD18 (Dragan et al.,
2006a). Moreover, in presence of substrates metabolic flux ratio
analysis revealed a relative increase in the TCA cycle flux of strain
CAD18 (expresses hCYP21A1) showing approximately the same
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relative magnitude as the recorded decrease of the oxygen con-
sumption rate and the amount of generated ROS (Dragan et al.,
2006a). These findings might be interpreted as a sign for the
competition of intracellular processes for oxygen leading to the
observed activity reduction of the respiratory electron transfer
systems in favor of the overexpressed microsomal P450s. The ex-
perimental data were consistent with the simulation results gained
by numerically solving the developed kinetic model (Dragan et al.,
2006a). The data showed a similar decrease in oxygen consump-
tion and ROS generation under increasing hCYP21A1 substrate
concentrations and, hence, increasing CYP21 activity. In addi-
tion, in this model oxygen plays a double role within the P450
systems. On one hand it acts as a terminal electron acceptor
while on the other it acts as a cosubstrate in the P450 reaction
(see equation system 1.3).
Overall, simulation results were numerically well comparable
to the experimentally gained figures concerning product forma-
tion rate, oxygen consumption rate, and ROS generation for both
CAD8 and CAD18 (data not shown).2 To further test the answer
of the kinetic model to different parameter inputs, the simulation
was extended to comprise two varying factors at the same time
(data not shown). Hereby, the increased oxygen consumption
rates in presence of hCYP21A1 and absence of substrates were
the only deviations from experimental results (data not shown).
Nevertheless, the output of the model should be rather seen qual-
itatively since kinetics can be potentially described by a differ-
ent set of reaction combinations. It should be also kept in mind
that the model only delivered rates displayed by a ’P450 only’-
system which were devoid of additional cellular oxygen consump-
tion rates. Hence, the model failed to reproduce the generally
2Comparing the simulation data with experimental values can be accomplished by divid-
ing the simulated figures by 166 in order to yield rate and concentration values referred to
one liter of cell suspension. Further reduction of the oxygen consumption rate must be taken
into account due to the lower cell density used in the MTP assays (Dragan et al., 2006a).
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higher oxygen uptake of the parent strain MB175 although it cor-
rectly described the decrease in total oxygen consumption in pres-
ence of substrates (data not shown). Moreover, steroid metabolite
formation rates were quite consistent with experimentally deter-
mined rates within the tested range of substrate concentration
(not shown).
A further important constituent of a P450 system is the source
of reduction equivalents, NADPH (see equation system 1.3). Look-
ing at the pentose phosphate pathway (PPP) as one possible
NADPH-source by metabolic flux ratio analysis revealed no dif-
ferences between the presence and absence of substrates in case
of strain CAD18 (Dragan et al., 2006a). This leads to the conclu-
sion that fission yeast did not upregulate the PPP in order to re-
act on the NADPH demand induced by the P450-dependent bio-
transformation. Of course, the existence of alternative NADPH
sources that were not included in the reaction network of the
metabolic flux ratio analysis might have been overlooked. How-
ever, at first sight the experimental results conform the simulation
results where the consumption of oxygen, the generation of ROS,
and of products first reacted to decreasing NADPH concentra-
tion at values below 1 µM (not shown). This weak dependence
on the NADPH concentration could be experimentally confirmed
by Zehentgruber et al. (2010) who recently demonstrated that
the intracellular NADPH concentration of around 20 µM kineti-
cally reacted to the presence of a biotransforming P450 system.
However, after reaching equilibrium it stabilized at values be-
tween 5 µM and 10 µM. Consequently, it could be hypothe-
sized that there might be more room for further improvement
of the 17α-hydroxyprogesterone biotransformation rate of strain
CAD18. Indeed, Zehentgruber et al. (2010) could readily increase
the initial biotransformation rate of 17α-hydroxyprogesterone 6-
fold over the value shown by strain CAD18 (Dragan et al., 2006a).
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Conclusions
In this work the heterologous and functional expression of the
human CYP11B1 could be achieved using fission yeast as a host
(Dragan et al., 2005). As was expected from previous work (Bu-
reik et al., 2002b), the human CYP11B1 was correctly localized
to the host’s mitochondria and received electrons from a present
electron transfer chain. Together with a formerly generated fis-
sion yeast strain expressing the human CYP11B2 (Bureik et al.,
2002b), the fission yeast system could be successfully used for the
discovery of a hit compound that showed the selective inhibition
of one of the closely related isoforms (Bureik et al., 2004).
A further confirmation for use of fission yeast as a host was
achieved by the functional expression of two microsomal P450s,
CYP17A1 (Dragan et al., 2006b) and CYP21A1 (Dragan et al.,
2006a). Thereby, it could be shown that fission yeast was able
to sustain a significant metabolite formation rate during whole-
cell biotransformation. A significant increase of the space-time
yield of CAD18 could be later achieved by Zehentgruber et al.
(2010). The biotransformation data imply the presence of an
electron transfer chain in the host that is able to support human
microsomal P450s. Moreover, it could be shown that both fission
yeast strains could be used for the screening of specific inhibitors
(Dragan et al., 2006b). Later studies showed that the coexpres-
sion of human CYP21A1 and CPR allowed the application of a
CYP21A1 expressing strain to the structural determination of a
sports doping agent metabolite (Zo¨llner et al., 2010).
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Appendix A
Proteins, peptides, genes, and
DNA sequences
Table A.1: Proteins, peptides, genes, and DNA sequences used in this work.
Abbreviation Representation Source
AdR adrenodoxin reductase Homo sapiens
Adx adrenodoxin Bos taurus
AmpR ampicillin resistance gene, β-lactamase Escherichia coli
ars1 autosomally replicating sequence Schizosaccharomyces pombe
COXVI cytochrome c oxidase subunit VI Saccharomyces cerevisiae
CYP11A1 cholesterol side-chain cleavage enzyme Homo sapiens
CYP11B1 steroid 11β-hydroxylase Homo sapiens
CYP11B1 aldosterone synthase Homo sapiens
CYP17 CYP17A1, 17α-hydroxylase/17,20-lyase Homo sapiens
CYP21 CYP21A1, steroid 21-hydroxylase Homo sapiens
Etp1 electron transfer protein Schizosaccharomyces pombe
his6 hexahistidine tag artificial
LEU2 β-isopropylmalate dehydrogenase Saccharomyces cerevisiae
nmt1 no message in thiamine Schizosaccharomyces pombe
ORI origin of replication Escherichia coli
PCMV promoter Cytomegalovirus
PfuPOL DNA polymerase I Pyrococcus furiosus
Pk 14 aa peptide sequence from P and V proteins Simian Virus 5
Pnmt1 promoter region of nmt1 Schizosaccharomyces pombe
T4 ligase ligase enterobacteriophage T4
TaqPOL DNA polymerase I Thermus aquaticus
TurboPfu modified DNA polymerase I Pyrococcus furiosus
ura4 orotidine 5’-phosphate decarboxylase Schizosaccharomyces pombe
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Abstract
Genetically engineered microorganisms are being increasingly used for the industrial production of complicated chemical com-
pounds such as steroids; however, there have been few reports on the use of the fission yeast Schizosaccharomyces pombe for this
purpose. We previously have demonstrated that this yeast is a unique host for recombinant expression of human CYP11B2 (aldo-
sterone synthase), and here we report the functional production of human CYP11B1 (steroid 11b-hydroxylase) in S. pombe using
our new integration vector pCAD1. In the human adrenal, the mitochondrial cytochrome P450 enzyme CYP11B1 catalyses the con-
version of 11-deoxycortisol to cortisol, a key reaction in cortisol biosynthesis that in addition is of fundamental interest for the tech-
nical synthesis of glucocorticoids. We observed that the endogenous mitochondrial electron transport system detected previously by
us is capable of supplying this enzyme with the reducing equivalents necessary for steroid hydroxylation activity. Under optimised
cultivation conditions the transformed yeasts show in vivo the inducible ability to efficiently and reliably convert deoxycortisol to
cortisol at an average rate of 201 lM d1 over a period of 72 h, the highest value published to date for this biotransformation.
 2004 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
Keywords: Cortisol; CYP11B1; Directed integration; Fission yeast; Schizosaccharomyces pombe; Steroid 11b-hydroxylation
1. Introduction
The present state of yeast expression technology of-
fers a great potential for the production of pharmaco-
logical target proteins and various enzymes of
industrial interest. In the academic field researchers have
made use of the fission yeast Schizosaccharomyces
pombe for decades and it has proven to be a very suc-
cessful model for the investigation of various gene func-
tions like cell cycle studies [1], and after the complete
sequencing of its genome [2] and with the wide variety
of established genetic methods available [3,4] there is po-
tential for more biotechnological applications of this
organism. Previous investigations of our group have
suggested that one promising application of recombi-
nant fission yeasts are steroid hydroxylations catalysed
by cytochrome P450 enzymes (P450s) [11].
Mammalian cytochrome P450 enzymes generally per-
form oxidation reactions on their organic substrates
while reducing molecular oxygen with electrons delivered
from NADPH via electron transfer proteins. In the case
of themitochondrially localised P450s, these two proteins
1567-1356/$22.00  2004 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
doi:10.1016/j.femsyr.2004.12.001
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are adrenodoxin (Adx) and adrenodoxin reductase
(AdR). The second is a flavoprotein which oxidises
NADPH and transfers electrons on the iron-sulfur pro-
tein Adx, which in turn supplies electrons to the reaction
cycle of the P450. A prominent example of a mitochon-
drial P450 is CYP11B1 (steroid 11b-hydroxylase), which
is expressed in the zona fasciculata/reticularis of the hu-
man adrenal and converts 11-deoxycorticol (RSS) to cor-
tisol (F), the major human glucocorticoid [6].
Glucocorticoids are used as important antiinflamma-
tory drugs and generally require an 11b-hydroxy group
as a functionally essential entity. During the industrial
synthesis of these compounds, the microbiological intro-
duction of the 11b-hydroxy group into the steroid scaf-
fold represents the most costly synthesis step and also
the one wherein most of the losses occur due to the for-
mation of by-products. Several decades ago, studies
were done to identify 11b-hydroxylating micororgan-
isms, and it was shown that the fungi Cunninghamella
blakesleeana or Curvularia lunata could convert RSS,
which is accessible from diosgenin or sterols, to cortisol
[7,8]. The 11b-position is axial and therefore more
strongly hindered by 1,3-diaxial interactions with the
C18- and C19-methyl groups and the 8b-hydrogen atom
than the equatorial 11a-position. This is considered to
be the reasonwhy 11b-hydroxylation proceeds with lower
yields and more side reactions as compared with the
11a-hydroxylation [9]. Comparative studies on 11b-
hydroxylase activity demonstrated C. lunata to be more
effective than Streptomyces fradia and C. blakesleeana
[10]. With the tremendous advance of molecular biology
since the first cortisol-producing bioconversions were
undertaken, expression of CYP11B enzymes in microor-
ganisms emerges as the probable path that development
in this field will take. While no functional bacterial
expression systems for human or bovine CYP11B en-
zymes are at hand, efforts have concentrated on using
the yeasts Saccharomyces cerevisiae [5] and S. pombe
[11], and cortisol-producing strains have been devel-
oped. However, the highest bioconversion activities
published to date were in the range of 13 lM d1 [5]
and therefore too low to consider their use for industrial
applications. The aim of this study was: (i) to create a
fission yeast strain that strongly and stably expresses hu-
man CYP11B1 and (ii) using this strain to improve cor-
tisol production on the laboratory level to conversion
rates that come in the vicinity of industrial relevance.
2. Materials and methods
2.1. Chemicals
Radioactive 11-deoxycortisol was obtained from
NEN (Boston, MA), non-radioactive steroids were from
Sigma (Deisenhofen, Germany).
2.2. Media and general techniques
Media and genetic methods for studying fission yeast
have been described in detail [3,4]. General DNA
manipulation methods were performed using standard
techniques [12].
2.3. Expression vector and cDNA
We developed an integration vector named pCAD1
(Fig. 1) that is an improved version of the pINT5 vector
(P. Wagner, unpublished results) and allows strong
expression of the gene of interest under control of the
nmt1 promoter [13]. Using pCAD1, the protein of inter-
est may be expressed with two C-terminal tags, a hexa-
histidine tag and a Pk tag, respectively; while the
addition of polyhistidine tags is widely used for purifica-
tion with metal-chelating resins and sometimes can also
have a stabilising effect on the expressed protein [14], the
Pk tag represents an immunological epitope that has
been shown to work very well in S. pombe [15].
For construction of pCAD1-CYP11B1, we PCR-
amplified the CYP11B1 cDNA to introduce NdeI and
BamHI sites. The resulting PCR product was cloned
into pcDNA3.1/CT-GFP-TOPO (Invitrogen; Carlsbad,
CA) and then subcloned into pCAD1 using NdeI and
BamHI to yield pCAD1-CYP11B1. Sequencing of the
Fig. 1. Vector map of pCAD1-CYP11B1. All sequences are available
from the authors by request. Relevant restriction sites are shown.
Leu1Loc: gene fragments of the leu1 gene that serve as integration
target sequences; AmpR: ORF for b-lactamase; nmt1: nmt1 promoter;
Cyp11B1: ORF for human steroid 11b-hydroxylase; his6: hexahistidine
tag; Pk: Pk epitope; ura4: ORF for orotidine monophosphate
decarboxylase, complements ura4.dl18 in S. pombe. A NotI digest of
this plasmid yields an integration construct with flanking leu1
sequences.
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CYP11B1 cDNA revealed no alterations compared to
the wild-type sequence [16].
For transformation of fission yeast, pCAD1-
CYP11B1 was digested with NotI to yield a 2.0-kb frag-
ment containing the pUC-derived sequences and a
6.1-kb integration fragment containing the expression
cassette, the ura4 marker, and flanking leu1 sequences.
This larger fragment was purified by agarose gel chro-
matography and used for transformation.
2.4. Transformation of S. pombe
We used strain NCYC 2036 (h ura4-D18) for trans-
formation, but any strain containing a functional leu1
gene and an ura4 mutant is suited for transformation
by pCAD1. Transformation was done using whole cells
made competent by the lithium acetate method [4],
yielding the new strain SZ1. Transformed cells were pla-
ted on EMM with 0.1 g l1 leucine and 5 lM thiamine
and incubated at 30 C. Transformants were checked
for leucine auxotrophy by replica plating, since the tar-
geted integration of pCAD1 by homologous recombina-
tion occurs at the leu1 locus.
2.5. Protein preparation and immunodetection
A total amount of 2.5 · 108 cells were centrifuged at
3000g for 5 min and resuspended in 5 ml water. After
a second centrifugation step, the cells were resuspended
in 200 ll of 100 mM Tris/SO4, pH 9.4, mixed with 200 ll
of sorbitol and incubated at room temperature for
10 min. Following centrifugation (3000g, 5 min) and dis-
carding of the supernatant, the cells were resuspended in
1 ml of 1.2 M sorbitol, 20 mM KH2PO4, pH 7.5, and
incubated at 30 C with 20 mg of Zymolyase 20 T
(ICN Biomedicals, Aurora, OH). Incubation at 30 C
was done until the spheroplast ratio reached 80–100%.
The cells were then centrifuged (3000g, 5 min) and resus-
pended in protein extraction buffer (20 mM Tris/Cl, pH
7.5, 5 mM MgCl2, 2 mM EDTA, 1 mM DTE, 1 g l
1
IGEPAL (Sigma), 1 mM PMSF). Cell breakage was
performed in a Potter homogeniser with 900 rpm in an
ice water bath.
Nuclei and cell debris were pelleted at 1000g for 5 min;
from the supernatant mitochondria were isolated after
centrifugation at 10,000g for 1 h and resuspended in
500 ll protein extraction buffer. The supernatant from
the mitochondria sedimentation step was considered to
be the cytosolic fraction. SDS-PAGE and Western-blot
analysis were performed using standard techniques [12].
An a-Pk antibody (MCA1360) obtained from Serotec
(Oxford, England) and a secondary peroxidase coupled
a-rabbit antibody (DakoCytomation; Glostrup, Den-
mark) were used for immunologic detection. Visualisa-
tion was done using the ECLPlus Western-blot
detection kit from Amersham (Piscataway, NJ).
2.6. Steroid hydroxylation assays
Biotransformation of RSS to F was essentially done
as described recently [11]. Briefly, SZ1 cells were grown
to stationary phase in EMM with leucine, washed once
with EMM and resuspended in 10 ml EMM with leu-
cine. RSS was added to a final concentration of 5 mM
and 2 lCi [3H]RSS were added for radioactive identifi-
cation. The assay cultures were shaken in 300-ml Erlen-
meyer flasks for 72 h at 30 C. At several time points
samples of 500 ll were extracted with an equal volume
of chloroform and separated by HPTLC as described.
Steroids were identified after exposure to Fuji imaging
plates and quantified on a phosphoimager (BAS-2500,
Fuji; Stamford, CT). Daily production rates for cortisol
(CR(F)) were calculated from three independent
experiments.
3. Results and discussion
3.1. Expression of human CYP11B1 in fission yeast using
the integration vector pCAD1
Fission yeast strain NCYC 2036 was transformed
using pCAD1-CYP11B1 as described in Section 2. After
three days, colonies grown on selective media were
tested for the presence of CYP11B1 DNA by PCR. Po-
sitive clones were checked for correct integration at the
leu1 locus by replica plating onto agar plates containing
phloxine B but lacking leucine. The transformation pro-
cedure yielded strain SZ1 (h ura4-dl18 leu1::pCAD1-
CYP11B1). For detection of CYP11B1 protein, strain
SZ1 was grown in the absence of thiamine to induce
the strong nmt1 promoter, fractionated protein lysates
were prepared from this strain as well as from the paren-
tal strain NCYC 2036 and examined by Western-blot
analysis using an a-Pk antibody. As expected, CYP11B1
could be detected in SZ1 mitochondrial lysates but nei-
ther in mitochondrial lysates from NCYC 2036 nor in
the cytosolic fraction of SZ1, and its apparent molecular
weight of approximately 56 kDa is in good agreement
with the calculated mass of 59 kDa (Fig. 2). These data
show that, as in the case of human CYP11B2 [11], the
mitochondrial localisation sequence of human
CYP11B1 is completely functional in S. pombe.
3.2. Biotransformation of 11-deoxycortisol to cortisol
using strain SZ1
The functionality of the CYP11B1 enzyme was con-
firmed by steroid hydroxylation assays monitoring the
conversion of RSS to F. Mitochondrial P450 steroid
hydroxylases like CYP11B1 depend on an electron
transport chain that consists of the two proteins adreno-
doxin and adrenodoxin reductase. However, we recently
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have reported that after expression of human CYP11B2
(an enzyme that is closely related to CYP11B1) no co-
expression of these proteins is needed for efficient sub-
strate conversion by intact fission yeast cells, due to
the presence of an endogenous electron transport system
[11]. This endogenous electron transport system evi-
dently can also transfer electrons to human CYP11B1,
as we could detect high bioconversion activity in strain
SZ1 (see below). For improvement of the steroid
hydroxylation protocol a number of different assay con-
ditions were tested in order to reach both very efficient
and reproducible cortisol production values (data not
shown). When RSS bioconversion activity of SZ1 was
assayed according to the optimised procedure described
in Section 2, cortisol-producing activity steadily in-
creased from the beginning up to a maximum activity
of 225 ± 20 lM d1 measured after 42 h (Fig. 3). For
the total assay time of 72 h, bioconversion of RSS to
F occurred at an average rate of 201 ± 36 lM d1. Dur-
ing these experiments we discovered two additional ste-
roid bands of varying intensity that result from
modifications of the substrate RSS and are apparently
not due to CYP11B1 but to endogenous enzymes, as
they were also detected in experiments using wild-type
fission yeast. The intensity of these activities seems to
depend on growth conditions and substrate concentra-
tion (data not shown). For calculation of the bioconver-
sion rates presented in this work, these compounds were
treated as non-hydroxylated substrate (i.e. RSS) and
their formation thus lowered the reported cortisol pro-
duction rates to some extent. Nevertheless, these activity
values are higher by several orders of magnitude than
those obtained previously by us using a fission yeast
strain that expresses human CYP11B2 (aldosterone syn-
thase) and over-expresses the endogenous ferredoxin
etp1 [11], and they are also significantly higher than
the bioconversion rate that was obtained with S. cerevi-
siae expressing bovine adrenodoxin and CYP11B1 [5]
(Table 1). It is assumed that this strong increase in bio-
transformation activity is the result of several causes
that act in combination: (1) The CYP11B enzyme. A di-
rect and unambigious comparison of CYP11B enzyme
activities has not been possible so far due to the unavail-
ability of purified human CYP11B1 and CYP11B2.
However, after transient expression in mammalian
COS-1 cells human CYP11B1 displayed somewhat high-
er steroid 11b-hydroxylation activity than either human
CYP11B2 [17] or bovine CYP11B1 [18]. (2) The host
organism. It is known that the intracellular membrane
systems of fission yeast are more highly developed than
those of bakers yeast [19], and S. pombe has many dis-
tinct features in its mitochondria that separate it from
other fungi [20]. These facts are reflected by our observa-
tions that the localization sequences of human CYP11B
enzymes are fully functional in this yeast and that the
P450s are supplied with reducing equivalents from
endogenous electron transfer proteins like etp1 [11].
Thus, it can be speculated that the environment of fis-
sion yeast mitochondria is more favorable for mamma-
lian mitochondrial proteins than are the mitochondria
of other fungi. (3) The biotransformation protocol. As-
say conditions that allow a good oxygen saturation of
the culture were found to be favorable for efficient sub-
Fig. 2. Detection and sub-cellular localisation of CYP11B1 expressed
from pCAD1 in fission yeast by Western-blot analysis. Cytosolic and
mitochondrial protein preparations were separated by SDS/PAGE and
blotted onto nitrocellulose. Immunological protein detection was
carried out using an a-Pk tag antibody as described in Section 2. M:
protein standard; SZ1: fission yeast strain expressing the human
CYP11B1; NCYC 2036: parental strain of SZ1; cyt: cytosolic fraction;
mit: mitochondrial fraction.
Fig. 3. Time course of the cortisol production activity and the overall
daily production of cortisol by SZ1. The assay was carried out as
described in Section 2. CR(F) is the overall daily cortisol production
rate calculated for the period between t = 0 h and the indicated time
points. Data shown are mean values of triplicate measurements and
standard deviations are shown as error bars.
Table 1
Bioconversion of 11-deoxycortisol to cortisol in recombinant yeast strains expressing mammalian CYP11B enzymes
Strain (enzyme, organism) Assay duration Conversion rate (lM d1) Reference
MB224 (human CYP11B2, S. pombe) 24 h 0.0028 ± 0.0003 [11]
TGY73.4/pTG10120 + pTG10350 (bovine CYP11B1, S. cerevisiae) 72 h 12.7 ± 5.2 [5]
SZ1 (human CYP11B1, S. pombe) 72 h 201 ± 36 This work
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strate bioconversion (data not shown). However, this
point was not investigated systematically.
Our results demonstrate that within a comparably
short time significant improvements of the technologi-
cally important process under study could be reached,
and we are confident that optimisation of yeast strains
performing steroid 11b-hydroxylation by methods of
both molecular biology and bioprocess technology has
certainly not nearly reached its limits yet for either S.
cerevisiae or S. pombe. For example, experiments aiming
at the improvement of the components of mitochondrial
P450s by means of molecular evolution have been
undertaken (Bichet et al., unpublished results). More-
over, it would be expected that the efficiency of cortisol
bioproduction can be further enhanced by scaling-up
from shake-flask cultivation to sophisticated high-cell-
density fermentation techniques. Thus, it is foreseeable
that the current processes of cortisol production which
are run with phenotypically highly optimised but not
recombinantly modified fungi will encounter serious
competition by genetically engineered yeasts in the near
future.
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Abstract
Cytochrome P450s are haem-containing monooxygenases that catalyse a variety
of oxidations utilizing a large substrate spectrum and are therefore of interest
for biotechnological applications. We expressed human CYP21 in fission yeast
Schizosaccharomyces pombe as a eukaryotic model for P450-dependent whole-cell
biotransformation. The resulting strain displayed strong steroid hydroxylase activity
that was accompanied by contrary effects on respiration and non-respiratory oxygen
consumption, which combined to a significant decline in total oxygen consumption
of the cells. While production of ROS (reactive oxygen species) decreased, the TCA
cycle activity increased, as was shown by metabolic flux (METAFoR) analysis. Pentose
phosphate pathway (PPP) activity was found to be negligible, regardless of growth
phase, CYP21 expression or biocatalytic activity, indicating that NADPH levels in
Sz. pombe are sufficiently high to support an exogenous P450 without adaptations
of central carbon metabolism. We conclude from these data that neither oxygen
supply nor NADPH availability are limiting factors in P450-dependent biocatalysis
in Sz. pombe. Copyright  2006 John Wiley & Sons, Ltd.
Keywords: biotransformation; cytochrome P450; metabolic flux ratio analysis;
oxygen; Schizosaccharomyces pombe; steroid hydroxylation
Introduction
The cytochrome P450s are haem-containing mono-
oxygenases that catalyse a variety of oxidations
on a large amount of substrates. P450s utilize
two electrons from NAD(P)H to activate dioxy-
gen and are impressive for their ability to catalyse
the insertion of oxygen into allylic positions, dou-
ble bonds, or even into non-activated C–H bonds.
This ability to catalyse reactions that are difficult
to achieve chemically with high selectivity, espe-
cially in water, at room temperature and under
atmospheric pressure, makes P450 enzymes attrac-
tive for biotechnological applications (Urlacher
et al., 2004). However, some major disadvantages
still exist, explaining why few industrially rel-
evant processes exist. Most P450s display low
activity, limited stability, dependence on auxil-
iary electron transfer proteins and need of the
expensive co-factors NADH or NADPH. To over-
come some of these disadvantages, whole cell
oxidations with recombinant microorganisms that
express the desired P450s have been developed
by many researchers since the respective genes
became accessible. In addition, P450s have been
the target of extensive protein engineering studies,
including sophisticated methods of both rational
design and molecular evolution (e.g. Bottner et al.,
1996; Glieder et al., 2002; Lindberg and Negishi,
1989; Otey et al., 2004, 2006).
Currently, the technical use of P450-dependent
biotransformations is restricted to the hydroxy-
lation of steroids and aromatic synthons, and
the formation of dicarboxylic acids from alkanes
Copyright  2006 John Wiley & Sons, Ltd.
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(Urlacher et al., 2004). However, a large number
of reactions were developed at the laboratory scale,
using a variety of host organisms (e.g. Dragan
et al., 2005; Munzer et al., 2005; Nthangeni et al.,
2004), with the total synthesis of hydrocortisone
from a simple carbon source by a recombinant Sac-
charomyces cerevisiae strain being a major mile-
stone (Szczebara et al., 2003). The biotechnolog-
ical prospects of P450-dependent biotransforma-
tions are, among other topics (such as enzyme
activity and stability), closely related to the ques-
tions of co-factor regeneration and oxygen con-
sumption in whole cells, which we address in this
study. Human CYP21 (steroid 21-hydroxylase) was
expressed in the fission yeast Schizosaccharomyces
pombe to create a model strain for highly efficient
P450-dependent biotransformation in a eukaryote.
Using this model strain we investigated whether
P450 activity is limited by availability of oxygen
or NADPH. We also report the first metabolic-flux
and network analysis of fission yeast to provide
a reference dataset for Sz. pombe and to elucidate
whether metabolic fluxes are changed in the pro-
cess of P450-dependent biotransformation.
Materials and methods
Chemicals
Progesterone, 17α-hydroxyprogesterone, 11-deoxy-
corticosterone and 11-deoxycortisol were from
Sigma (Deisenhofen, Germany). 16α-hydroxypro-
gesterone was from Steraloids Inc. (Newport, RI,
USA). Steroid stock solutions were prepared in
HPLC-grade ethanol.
Media and general techniques
General DNA manipulation methods were per-
formed using standard techniques (Sambrook et al.,
1989). Media and genetic methods for studying fis-
sion yeast have been described in detail (Alfa et al.,
1993; Moreno et al., 1991). Briefly, strains were
generally cultivated at 30 ◦C in Edinburgh mini-
mal medium (EMM) with supplements of 0.1 g/l
final concentration as required. Liquid cultures
were kept shaking at 150 r.p.m. The correlation
of cell wet weight (CWW) to cell number was cal-
culated according to: CWW [g] = 3.33 × 10−10 ×
cell number. Thiamine was used at a concentration
of 5 µM throughout. Transformation of fission yeast
strain MB175 (h− ade6-M210 leu1-32 ura4-d118
his3-1 ) (Burke and Gould, 1994) and immuno-
logical protein detections were done as described
previously (Dragan et al., 2005).
Expression vector and CYP21 cDNA
We used the commercially available vector
pNMT1-TOPO (Invitrogen; Carlsbad, CA), which
allows strong expression in fission yeast under
the control of the nmt1 promoter (Maundrell,
1990). Using pNMT1-TOPO the protein of
interest is expressed with two C-terminal tags, a
hexahistidine tag and a Pk tag, respectively; the
Pk tag represents an immunological epitope that
has been shown to work very well in Sz. pombe
(Bureik et al., 2002; Craven et al., 1998). Plasmid
pGEM3Z–CYP21 (Nikoshkov et al., 1997), the
human CYP21 cDNA, was a kind gift from Walter
L. Miller (University of California, San Francisco,
CA). From this plasmid the CYP21 cDNA
was PCR-amplified using Pfu DNA polymerase
(Promega; Madison, WI). After attachment of
terminal 3′-adenosines the PCR product was cloned
into pNMT1-TOPO to yield pNMT1–hCYP21.
Sequencing of the cloned cDNA revealed the
following amino acid alterations for the human
CYP21 compared to Swiss-Prot entry PO8686:
duplication of Leu-9 as in allele CYP21A2∗2;
exchange Lys102Arg as in allele CYP21A2∗3; and
a Gly491Val mutation introduced by the reverse
primer.
Steroid hydroxylation assays
For steroid bioconversion, cells were grown to
early stationary phase (approximately 107 cells/ml
to 2.5 × 107 cells/ml) in EMM supplemented with
adenine, histidine and uracil in the absence of
thiamine. After centrifugation and washing with
EMM, the cells were resuspended in 10 ml EMM
with adenine, histidine and uracil to 5 × 107 cells/
ml. The suspension was then transferred to 250 ml
Erlenmeyer flasks where steroid concentrations
were adjusted to 1 mM. The 10 ml assay cultures
were shaken in Erlenmeyer flasks for 72 h at 30 ◦C
and 300 r.p.m. Samples were taken at 0, 24, 48
and 72 h. Steroids were extracted with chloroform
and analysed on a Jasco HPLC instrument (Tokyo,
Japan) composed of an auto-sampler AS-950, pump
Copyright  2006 John Wiley & Sons, Ltd. Yeast 2006; 23: 779–794.
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PU-980, gradient mixer LG-980-02 and an UV-
detector UV-975 equipped with a reversed phase
Nova-Pak C18 column from Waters (Milford,
MA, USA). Absorption was recorded at 240 nm,
peak detection and quantification were done using
the algorithm of the analysis software Borwin
version 1.50 from Jasco. Dilutions of respective
pure steroids were used as references and as inter-
nal standard references as well as for calibrations.
Oxygen consumption rate measurements
The change in the oxygen concentration cox of a
cell suspension solution is given by:
dcoxy
dt
= kLa(csat − coxy)+ r · X (1)
where kLa is the mass transfer coefficient of oxygen
between atmosphere and solution, csat is the oxygen
concentration at saturation, r is the respiration
rate per biomass and, finally X is the biomass.
In this work, the evolution of X with time is
negligible because of the short measuring period
compared to the generation time of Sz. pombe.
Fission yeast cells were cultured as described in
the section on steroid hydroxylation assay, under
fully induced expression conditions, washed once
with EMM and resuspended in fresh EMM plus
necessary supplements. Prior to measurement, an
aliquot of cells was transferred to a 1.5 ml flask
at a cell density of 5 × 106 cells/ml and incubated
with the appropriate concentration of steroids in
a 2.5% (v/v) ethanolic solution of EMM plus
supplements for 5 min. Immediately following the
incubation step, aliquots of 200 µl were transferred
to the wells of a sensor-bearing microtitre plate
(Precision Sensing GmbH, Regensburg, Germany)
and oxygen consumption was monitored in 1.5 min
intervals for 1 h, using the SAFIR fluorescence
reader (Tecan; Geneva, Switzerland). The kLa value
was determined experimentally according to the
manufacturer’s recommendations and was found to
be 0.0119 ± 0.0002/min in EMM. The integrated
form of equation 1 was fitted to the cell suspension
data by the least squares method, using ORIGIN
(OriginLab, Northampton, MA, USA).
Cytometric detection of reactive oxygen
species
Cells were grown as described above, washed once
with EMM and resuspended to 5 × 107 cells/ml.
Steroid concentrations were set to 1.0 mM with an
ethanol content of 2.5% (v/v); 1 ml was transferred
to a modified 1.5 ml Eppendorf vial with a 200 µl
pipette tip pushed through the cap and then cut in
the middle (so-called tip-tube). This simple modi-
fication assured a better aeration during the assay
period. After 8 h incubation at 30 ◦C and 1400
r.p.m., cells were subjected to ROS determination
and HPLC analysis. For the cytometric detection
of ROS, 250 µl cell suspension were incubated for
30 min at 37 ◦C with 2 µl 250 µM dehydroethid-
ium (DHE) dissolved in DMSO. After washing
with water, cells were resuspended in 1 ml water
and analysed on a FACSCalibur instrument (BD
Biosciences; Franklin Lakes, NJ), using an excita-
tion wavelength of 488 nm and the detector band
pass filter set to 585 ± 21 nm (FL2 channel). This
setting allows the detection of both ethidium and 2-
hydroxyethidium, both of which are formed from
DHE by superoxide anion oxidation (Zhao et al.,
2005). At least two cytometric measurements were
carried out for each cell suspension solution.
13C-labelling experiments
All labelling experiments were done in batch
cultures assuming pseudo-steady-state conditions
during the exponential growth phase (Fischer
and Sauer, 2003; Sauer et al., 1999; Wittmann
and Heinzle, 2001). 13C-labelling of proteinogenic
amino acids was achieved by growth on 5 g/l
glucose as a mixture of 80% (w/w) unlabelled
and 20% (w/w) uniformly labelled [U-13C6]glucose
(13C, >98%; Isotech; Miamisburg, OH). Cells from
an overnight minimal medium culture were washed
and used for inoculation, setting up a cell den-
sity of 105 cells/ml. Where desired, steroid con-
centrations were set to 1 mM. The cell suspen-
sion was incubated at 30 ◦C and 300 r.p.m. Cell
density was monitored microscopically by count-
ing cells with a haemocytometer. 13C-labelled
biomass aliquots were harvested during the mid-
exponential growth phase at 5 × 106 cells/ml and
at early stationary phase at 2 × 107 cells/ml. A
sample aliquot was subjected to HPLC steroid
analysis. The cells were harvested by centrifuga-
tion, washed once with sterile water and hydrol-
ysed in 150 µl 6 M HCl at 105 ◦C for 24 h. The
hydrolysate was dried in a heating block at 80 ◦C
under a constant airflow. The free amino acids were
Copyright  2006 John Wiley & Sons, Ltd. Yeast 2006; 23: 779–794.
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derivatized at 85 ◦C for 1 h using 15 µl dimethyl-
formamide and 15 µl N -(tert-butyldimethylsilyl)-
N -methyl-trifluoroacetamide (Dauner and Sauer,
2000; Wittmann et al., 2002). GC–MS analy-
sis was carried out as reported recently (Fischer
and Sauer, 2003), using a previously described
biochemical reaction network (Blank and Sauer,
2004).
METAFoR analysis using amino acids mass
isotopomer data
The GC–MS data represent sets of ion clusters,
each showing the distribution of mass isotopomers
of a given amino acid fragment. For each fragment
α, one mass isotopomer distribution vector (MDV )
was assigned:
MDVα =


(mo)
(m1)
(m2)
. . .
(mn)

 with
∑
mi = 1 (2)
where m0 is the fractional abundance of the lowest
mass and mi>0 are the abundances of molecules
with higher masses. To obtain the exclusive mass
isotope distribution of the carbon skeleton, cor-
rections for naturally occurring isotopes in the
derivatization reagent and the amino acids were
performed as described previously (Fischer and
Sauer, 2003), followed by calculations of the amino
acid (MDVAA) and metabolite (MDVM) mass dis-
tribution vectors. Metabolic flux ratios were calcu-
lated from the MDVM as previously described for
S. cerevisiae (Blank and Sauer, 2004).
Results
Expression of human CYP21 in fission yeast
and steroid bioconversion
Fission yeast strain MB175 was transformed with
pNMT1–hCYP21 to yield strain CAD18 (h−
ade6-M210 leu1-32 ura4-D18 his3-1/pNMT1-
hCYP21 ). For immunological protein detection,
cells were grown in the absence of thiamine to
induce the strong nmt1 promoter. Protein lysates
were prepared from CAD18 and parental strain
MB175 and examined by Western blot analy-
sis, using an α-Pk antibody. As expected, the
human CYP21 protein could readily be detected
in strain CAD18, but not in the parental strain
MB175, and the apparent molecular weight of
the enzyme is in good agreement with the cal-
culated mass of 58 kDa (Figure 1A). Cells of
strain CAD18 do not show an altered pheno-
type when observed under the microscope, but
grow significantly more slowly than the parental
strain (data not shown). Steroid bioconversion
assays revealed the strong steroid 21-hydroxylation
activity of these cells: The conversion of pro-
gesterone to 11-deoxycorticosterone and that of
17α-hydroxyprogesterone to 11-deoxycortisol were
efficiently catalysed by CAD18, with essentially
no formation of byproducts under these condi-
tions (Figure 1B). Parental strain MB175 showed
no significant conversion of substrates to byprod-
ucts except for progesterone, where careful reten-
tion time analysis revealed a possible minor
contamination of 11-deoxycorticosterone with an
unknown product that accounted for less than
4.0% of the total steroid concentration (data not
shown). The maximal conversion rate of proges-
terone is attained during the first 24 h (Figure 1C)
and was determined to be 21 ± 1 µM/day [or
1.26 ± 0.06 µmol/g (CWW)/day], while for 17α-
hydroxyprogesterone the rate was 259 ± 9 µM/day
[or 15.6 ± 0.5 µmol/g (CWW)/d], which is one
order of magnitude higher than for the former
substrate. Biotransformations with recombinant
baker’s yeast expressing bovine CYP21 reported
previously (Sakaki et al., 1990, 1991; Szczebara
et al., 2003) might have had significantly lower
steroid conversion rates, but the experimental set-
up was not entirely comparable. Nevertheless, the
strong steroid hydroxylation activity of fission
yeast strain CAD18 demonstrates its usefulness as a
eukaryotic model for P450-driven biocatalysis. As
expected, endogenous P450 oxidoreductase (CPR)
is capable of reducing heterologously expressed
P450, which renders co-expression of a mammalian
CPR unnecessary.
Oxygen consumption and ROS production by
fission yeast expressing human CYP21
Cytochrome P450-enzymes generally catalyse hy-
droxylation reactions of the type:
R − H + NADPH + H+ + O2
P450
−−→R − OH + NADP+ + H2O
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Figure 1. Heterologously expressed human CYP21 can convert progesterone to 11-deoxycorticosterone and
17α-hydroxyprogesterone to 11-deoxycortisol. (A) Detection of CYP21 protein expression in strain CAD18 by Western
blot analysis. After cell lysis, proteins were separated by SDS–PAGE, blotted onto nitrocellulose and probed with
α-Pk-tag. Visualization was carried out as described in Materials and methods. WT, wild-type fission yeast strain MB175
(parental strain); PM, protein reference marker. (B) Heterologously expressed human CYP21 is strongly active in fission
yeast. The two upper chromatograms (60 min run, 17α-hydroxyprogesterone as internal standard) show the conversion
of progesterone by CAD18, whereas the two chromatograms below (25 min run, 11-deoxycorticosterone as internal
standard) show the conversion of 17α-hydroxyprogesterone by CAD18. The peak denoted by an asterisk elutes at
about 2.5 min and appears also in ethanol-treated wild-type fission yeast (data not shown). Prog, progesterone; DOC,
11-deoxycorticosterone; 17Prog, 17α-hydroxyprogesterone; RSS, 11-deoxycortisol. (C) Time course of product formation.
Biotransformation assays were carried out as described in Materials and methods, with 1 mM initial steroid concentrations.
At different time points samples were taken from the culture, extracted and analysed by HPLC. Points are mean values
with bars representing the standard error of means calculated from at least three independent experiments (non-visible
error bars indicate a low standard error)
(Bernhardt, 1996), and the questions of co-
factor regeneration and oxygen consumption in
whole cells are therefore important issues for
the assessment of biotechnological applications.
We thus monitored the oxygen consumption
rate of fission yeast with or without CYP21
expression and in the presence or absence of
the steroid substrates. Oxygen consumption of
the parental strain MB175 is not affected by
either steroid as compared to solvent control
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Figure 2. Oxygen consumption and reactive oxygen species production by fission yeast expressing human CYP21. (A, B)
Comparison of the oxygen consumption rate of MB175 (A) and CAD18 (B) in the presence of different concentrations of
steroid substrates. Cells were incubated with different steroid concentrations, as indicated, or with 2.5% ethanol (solvent
control). Column values represent means gained from eight independent experiments, with standard errors of mean shown
as error bars. Prog, progesterone; 17Prog, 17α-hydroxyprogesterone; EtOH, ethanol. (C, D) ROS production by MB175
(C) or CAD18 (D). Cells were treated as indicated and analysed cytometrically, either directly after addition of steroids
or solvent, respectively (light grey bars), or after an incubation period of 8 h (dark grey bars). Fluorescence units were
normalized to the solvent control (i.e. ethanol) of the parental strain at t = 0 h. Data shown are the means of fluorescence
intensity means gained from the FL2 channel, with the standard error of mean calculated using Gaussian error propagation
(n = 6). EtOH, ethanol; Prog, 1 mM progesterone; 17Prog, 1 mM 17α-hydroxyprogesterone
(Figure 2A). However, we detected a significant
decline of oxygen consumption after CYP21
expression in presence of 1.0 mM progesterone or
17α-hydroxyprogesterone, which is not observed
at lower steroid concentrations (Figure 2B). More
specifically, the oxygen consumption rate dropped
from values around 7.6 ± 0.1 µM/min (solvent
control) to 5.9 ± 0.1 µM/min, when cells were
treated with 1.0 mM progesterone (two-sided t-
test against control; p = 3.86 × 10−5, n = 8) and
to 6.1 ± 0.1 µM/min for treatment with 1 mM
17α-hydroxyprogesterone (two-sided t-test against
control; p = 2.67 × 10−5, n = 8), respectively,
which is a relative decrease in oxygen consumption
of about 20% for both substrates. In addition, we
generally observed a higher oxygen consumption
rate in the parental strain MB175 (approx.
9.0 µM/min) as compared to CAD18 (approx.
7.5 µM/min).
At first glance, after the introduction of an addi-
tional oxygen-consuming process (i.e. the CYP21
reaction), an increase in oxygen demand of the cells
would have been rather expected than the decrease
that we observed. In search for an explanation of
this observation, we developed an algorithm that
simulates non-respiratory oxygen consumption by
the heterologously expressed CYP21 and by the
endogenous microsomal P450 systems; the latter
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Figure 3. Model of electron flow and oxygen consumption
by the microsomal P450 system in fission yeast strain
CAD18. CPR is reduced by NADPH and then transfers
electrons to either P450s or oxygen. The P450s in turn
either hydroxylate their respective substrates (i.e. coupling
of NADPH consumption to product formation) or generate
ROS (uncoupling). S and P indicate substrates and products
for the respective cytochromes. The dashed arrows indicate
reactions that are reduced as a result of CYP21 expression
consist of the putative proteins CPR (syn. ccr1 ;
a predicted P450 oxidoreductase), CYP51 (syn.
erg11 ; a predicted sterol C-14α demethylase) and
CYP61 (syn. erg5 ; a predicted sterol C-22 desat-
urase), respectively (Wood et al., 2002). Since it
is known that the microsomal P450 system of
yeast is a major source of reactive oxygen species
(ROS; Rosenfeld et al., 2002), the model takes
both substrate hydroxylation and ROS production
into account (Figure 3). A system of differential
equations (described in the Appendix) was used to
quantitatively simulate oxygen consumption over
time with respect to the amount of CYP21 and its
substrates. Of course, these data only describe the
oxygen consumption by the cytochrome P450 sys-
tems and disregard all other cellular processes that
contribute to the overall oxygen consumption of
the fission yeast cells. The calculations show that
in the presence of the highest concentration of the
substrate 17α-hydroxyprogesterone, oxygen con-
sumption of the system decreases successively with
rising CYP21 protein levels (Figure 4A). Like-
wise, oxygen consumption decreases successively
with rising substrate concentrations in the presence
of maximum CYP21 concentration (Figure 4B),
Figure 4. Simulation of total oxygen consumed by the sys-
tem shown in Figure 1 as a function of time. (A) Simulation
of total oxygen consumption against increasing effective
concentrations of CYP21 in the presence of the substrate
17α-hydroxyprogesterone (17Prog). Effective CYP21 con-
centrations are 0 nM (light grey line), 8.3 nM (middle grey
line), 83 nM (dark grey line) and 830 nM (black line), respec-
tively. (B) Simulation of total oxygen consumption against
increasing effective concentrations of the substrate 17Prog
in the presence of 830 nM CYP21. Effective 17Prog concen-
trations were 0 nM (light grey line), 1.5 µM (middle grey line),
15 µM (dark grey line) and 150 µM (black line), respectively.
For further details on all parameters, see Appendix
as shown for 17α-hydroxyprogesterone. Similar
graphs were obtained using progesterone as sub-
strate (data not shown). The main reason for these
effects is the strong complex generation between
CYP21 and its substrate (equation A12) followed
by efficient formation of the CPR–CYP21–SCYP21
complex (equation A18), which counteracts both
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CPR-mediated ROS production and interactions
between CPR and endogenous CYP51 or CYP61.
Importantly, the oxygen concentration in the sys-
tem is one of the most decisive parameters of the
system, with small changes in this value causing
significant changes in both oxygen consumption
and substrate conversion; by contrast, variation of
the NADPH concentration by up to three orders of
magnitude does not give rise to strong effects (data
not shown).
In order to substantiate the conclusions drawn
from the simulation, we cytometrically monitored
ROS production in strains CAD18 and MB175
in the presence or absence of steroid substrates
(Figure 2C, D). In the parental strain MB175
we observed a slight but significant suppression
of ROS production when measured immediately
after adding 1.0 mM progesterone (two-sided t-
test against ethanol value; p = 9.58 · 10−5, n = 6)
or 1.0 mM 17α-hydroxyprogesterone (two-sided t-
test against ethanol value, p = 3.96 · 10−4, n = 6),
respectively, to the media (Figure 2C). When treat-
ing strain CAD18 with solvent only, a somewhat
elevated mean fluorescence value was found as
compared to the parental strain, and the same
ROS suppressive effect could be observed directly
after the addition of steroids (Figure 2D). However,
upon longer incubation periods with both steroid
substrates, we observed strong differences in the
ROS content of both strains. While in MB175 ROS
production rises by 40% after prolonged treatment
with ethanol or 1.0 mM 17α-hydroxyprogesterone
and even up to 70% after progesterone treatment,
this is not at all the case in strain CAD18 (compare
dark grey columns in Figure 2C, D). The biotrans-
formation rate of CAD18 was monitored in parallel
by HPLC analysis and confirmed strong CYP21
activity (data not shown). These results demon-
strate that, even under conditions of strong P450-
dependent steroid hydroxylation activity, ROS pro-
duction is clearly lower in CAD18 than in MB175,
which supports our conclusions drawn from the
qualitative simulation.
Metabolic flux ratio analysis (METAFoR) for
Sz. pombe
To evaluate the impact of P450-driven biocatalysis
on respiratory oxygen consumption and NADPH
regeneration, we studied central carbon metabolism
of Sz. pombe by adapting the metabolic flux
ratio analysis (METAFoR) previously used for
S. cerevisiae and other yeasts (Blank et al., 2005;
Blank and Sauer, 2004) to quantify the intracel-
lular carbon flux distribution. When using a new
organism for 13C-tracer-based flux analysis, the
first step is to confirm the assumed network struc-
ture (Gombert et al., 2001; Maaheimo et al., 2001).
Therefore, we followed our recent report (Blank
et al., 2005) to evaluate the compartmented amino
acid biosynthesis of Sz. pombe. This analysis con-
firmed that the network structure of Sz. pombe
is basically identical to the major yeast model
Saccharomyces cerevisiae (data not shown). To
establish the influence of time of harvest for the
metabolic flux analysis in Sz. pombe, we quanti-
fied the intracellular carbon flux distribution dur-
ing exponential and stationary phase. Interestingly,
little change was observed overall, with the non-
oxidative pentose phosphate (PP) pathway and the
upper bound of the malic enzyme being the notable
exceptions (Figure 5A). The very similar datasets
might originate from the fact that Sz. pombe can-
not efficiently utilize ethanol as the sole carbon
source (de Jong-Gubbels et al., 1996), so no or
little metabolic activity occurs after glucose deple-
tion. In addition, we compared the metabolic flux
results to S. cerevisiae, a respiro-fermentative yeast
(Crabtree-positive), and to Kluyveromyces lactis, a
respiratory yeast (Crabtree-negative) in Figure 5B.
Since Sz. pombe is a respiro-fermentative yeast
(Heslot et al., 1970; Lloyd et al., 1983), it was
not unexpected that its carbon flux distribution was
more similar to that of S. cerevisiae than to that of
K. lactis. More specifically, the PP pathway con-
tributes little or not at all to glucose catabolism,
little or no malic enzyme or PEP carboxy kinase
(gluconeogenesis) activity is measured, and little
TCA cycle activity was present under these condi-
tions.
Influence of P450-driven biocatalysis on central
carbon metabolism
To investigate the influence of CYP21-driven
steroid 21-hydroxylation activity on the flux distri-
bution in central carbon metabolism, we quantified
the flux distribution using the above-described 13C-
based METAFoR analysis in strain CAD18. There
was essentially no flux through the PP pathway
in all experiments with fission yeast cells in this
study (Figure 6), regardless of P450 expression and
substrate conversion, which suggests a low impact
Copyright  2006 John Wiley & Sons, Ltd. Yeast 2006; 23: 779–794.
DOI: 10.1002/yea
METAFoR analysis during P450-dependent biocatalysis in Sz. pombe 787
Figure 5. Origin of metabolic intermediates in wild-type fission yeast. (A) Comparison of metabolic fluxes during
exponential growth (black bars) and stationary phase (white bars) in glucose batch cultures. (B) Comparison of Sz. pombe
(black bars) with the respiro-fermentative yeast S. cerevisiae (white bars; Blank and Sauer, 2004) and with the respiratory
yeast K. lactis (grey bars; Blank et al., 2005) during growth in glucose batch cultures. The standard deviations were estimated
from redundant mass distributions. cyt, cytosolic; mit, mitochondrial; ND, not determined
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Figure 6. The relative carbon flux distribution at major Sz. pombe central metabolism branch points during CYP21-driven
biocatalysis. Fission yeast strains and assay conditions are given in the bar graphs. The experimental errors were estimated
from redundant mass distributions
of the biocatalytic reaction on the overall NADPH
consumption rate. In contrast, the flux through the
TCA cycle significantly increased when CYP21
expression was induced and a steroid substrate was
present (Figure 6). Thus, P450-dependent steroid
bioconversion affects the TCA cycle, but not the
PP pathway, in fission yeast.
Discussion
In this study, we created a fission yeast strain
(CAD18) that strongly expresses the human steroid
hydroxylase CYP21 as a model system for the
study of a cytochrome P450-dependent biotrans-
formation in a eukaryotic host. Sz. pombe has
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previously been used as a host for the expression
of microsomal P450s (Yamazaki et al., 1993;
Yasumori, 1997, 1999), and the results obtained
in those studies as well as this work indicate
that the endogenous CPR is capable of reduc-
ing heterologously mammalian P450 enzymes.
Whole-cell biotransformation experiments using
CAD18 demonstrated strong activity of CYP21
expressed in Sz. pombe, with steroid hydroxy-
lation rates being significantly higher for the
conversion of 17α-hydroxyprogesterone to 11-
deoxycortisol compared to that of progesterone
to 11-deoxycorticosterone (Figure 1). This find-
ing correlates well with former reports, where the
apparent vmax for 17α-hydroxyprogesterone was
also considerably higher than for progesterone
(Lorence et al., 1989; Wu et al., 1991). Unexpect-
edly, CYP21-expressing cells showed lower oxy-
gen consumption than the parental strain, even in
the presence of the steroid substrates (Figure 2).
To explain this finding it can be helpful to
remember that CPR supplies reducing equiva-
lents required by P450 isoenzymes (which are a
large superfamily of mixed-function oxygenases
or monooxygenases found in all three domains
of life) and, although there are numerous func-
tional cytochrome P450 genes in mammals (e.g.
57 in human), there is only one CPR gene in
each species. Thus, a single CPR is responsible
for electron transfer to all the microsomal P450s.
The FMN domain of CPR has a similar func-
tion to that of the flavodoxins, which contain a
single non-covalent-bound FMN prosthetic group,
and can substitute for the low-potential ferredoxin
during growth under low-iron conditions. The low-
potential flavin, FAD, accepts two reducing equiva-
lents from NADPH (dehydrogenase flavin) and the
high-potential flavin, FMN, acts as a one-electron
carrier (flavodoxin-type flavin) for the net two-
electron transfer from NADPH to P450, which in
the case of fission yeast are only two: CYP51 and
CYP61. Experiments with S. cerevisiae suggested
that CPR can directly donate electrons to oxy-
gen when P450-dependent activity is low, which
accounts for a major part of non-respiratory oxygen
consumption (NOC) and causes significant produc-
tion of ROS (Rosenfeld et al., 2002). After strong
overexpression of CYP21 using the nmt1 promotor
(Maundrell, 1990), the amount of electron acceptor
proteins available to react with reduced CPR should
increase notably, resulting in a drop of CPR-caused
ROS production. CYP21, like all P450s (Yasui
et al., 2005), shows a certain degree of uncou-
pling and therefore, especially in the absence of its
steroid substrates, is a source of ROS itself. A qual-
itative simulation based on a competition model
showed that an increase of steroid concentrations
should indeed lead to a decline in overall oxy-
gen consumption (Figures 3, 4). This model also
explains the difference in basal oxygen consump-
tion between parental strain MB175 and CAD18
even in the absence of CYP21 substrates, and it
was corroborated by our finding that ROS produc-
tion is indeed lower in CAD18 than in MB175 after
incubation with progesterone or 17α-progesterone,
respectively (Figure 2). We conclude that this drop
in ROS production is the cause for the observed
decrease in overall oxygen consumption.
To obtain a reference dataset for the central car-
bon metabolism of wild-type fission yeast, we per-
formed a metabolic flux ratio analysis (METAFoR)
(Blank et al., 2005; Blank and Sauer, 2004; Fis-
cher and Sauer, 2003), which showed few dif-
ferences between exponentially growing and sta-
tionary phase cells and, in addition, confirmed
that Sz. pombe is a Crabtree-positive yeast (Heslot
et al., 1970; Lloyd et al., 1983; Veiga et al., 2000)
with a carbon flux distribution that is more simi-
lar to that of S. cerevisiae than to that of K. lactis
(Figure 5). More specifically, there is a low flux
through the TCA cycle during unlimited growth
on glucose, the PPP contributes little or not at
all to glucose catabolism, and hardly any malic
enzyme and PEP carboxy kinase (gluconeogene-
sis) activities were measured. After overexpression
of CYP21 and in the presence of its steroid sub-
strates, we observed a considerably higher relative
TCA cycle flux, while most other flux ratios were
rather robust in comparison to the reference (data
not shown). The increased TCA cycle flux could
reflect a rise in oxygen availability, since ROS
production decreases under these conditions (see
above).
In S. cerevisiae, the PPP and the cytosolic
NADP+-dependent acetaldehyde dehydrogenase
are the main sources of NADPH (Grabowska and
Chelstowska, 2003). Fission yeast also displays
acetaldehyde dehydrogenase activity (Tsai et al.,
1995; de Jong-Gubbels et al., 1996) but it is
not known whether this activity is NADP+-
dependent; the carbon flux through the PPP of
Sz. pombe remains constantly low, even during
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active biotransformation (Figure 6), which suggests
that the level of NADPH is sufficiently high
in Sz. pombe to support an exogenous P450
without adjustment of central carbon metabolism.
Yeast promotors are not nearly as strong as
their bacterial counterparts, and the membrane-
bound eukaryotic P450s display significantly lower
turnover rates in comparison to soluble bacterial
CYPs, so the problem of co-factor regeneration
does not seem to be limiting, at least under these
conditions. However, it cannot be excluded that
this picture might change when stronger yeast
promotors are identified and/or when molecular
evolution provides us with P450 mutants that
display significantly higher activities.
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Appendix
Reaction network
Generation of reactive oxygen species (ROS) by
CPR itself (Rosenfeld et al., 2002) is described by:
CPRred + 2O2
k1
−−→CPRox + 2ROS, (A1)
where we simplified the reaction by transferring
two electrons on two oxygen molecules. Each of
the P450s can form a complex with its substrate
(S and P indicate substrates and products for the
respective cytochromes) that is subject to a certain
degree of decomposition:
CYP51ox + SCYP51
k2
−−→CYP51ox • SCYP51, (A2)
CYP51ox • SCYP51
k3
−−→CYP51ox + SCYP51, (A3)
CYP61ox + SCYP61
k15
−−→CYP61ox • SCYP61, (A4)
CYP61ox • SCYP61
k16
−−→CYP61ox + SCYP61, (A5)
CYP21ox + SCYP21
k4
−−→CYP21ox • SCYP21, (A6)
CYP21ox • SCYP21
k5
−−→CYP21ox + SCYP21. (A7)
For simplification, the binding of products to the
P450s is neglected. We further assumed that the
generation of ROS by P450s occurs via an inter-
mediary CPR–P450 complex that, once formed,
sequentially binds two molecules of oxygen and
produces ROS.
CPRred + CYP51ox
k6
−−→CPRred • CYP51ox (A8)
CPRred • CYP51ox + 2O2
k7
−−→CPRox
+ CYP51ox + 2ROS (A9)
CPRred + CYP61ox
k17
−−→CPRred • CYP61ox (A10)
CPRred • CYP61ox + 2O2
k18
−−→CPRox
+ CYP61ox + 2ROS (A11)
CPRred + CYP21ox
k8
−−→CPRred • CYP21ox (A12)
CPRred • CYP21ox + 2O2
k9
−−→CPRox
+ CYP21ox + 2ROS (A13)
The following reactions describe the formation
of products by interaction with CPR:
CPRred + CYP51ox • SCYP51
k10
−−→CPRred • CYP51ox • SCYP51 (A14)
CPRred • CYP51ox • SCYP51 + O2
k11
−−→CPRox + CYP51ox + PCYP51 (A15)
CPRred + CYP61ox • SCYP61
k19
−−→CPRred • CYP61ox • SCYP61 (A16)
CPRred • CYP61ox • SCYP61 + O2
k20
−−→CPRox + CYP61ox + PCYP61 (A17)
CPRred + CYP21ox • SCYP21
k12
−−→CPRred • CYP21ox • SCYP21 (A18)
CPRred • CYP21ox • SCYP21 + O2
k13
−−→CPRox + CYP21ox + PCYP21 (A19)
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Finally, the regeneration of reduced CPR is accom-
plished by:
CPRox + NADPH + H+
k14
−−→CPRred + NADP+.
(A20)
All molecules are transferred to mathematical sym-
bolism as follows:
y1,CPRred; y2, oxygen; y3,CPRox; y4,
ROS; y5,CYP51ox; y6, SCYP51; y7,
complex CYP51–SCYP51; y8,CYP21ox; y9,
SCYP21; y10, complex CYP21–SCYP21; y11,
complex CPRred –CYP51; y12,CPRred –CYP21;
y13,CPRred –CYP51–SCYP51; y14, PCYP51;
y15, complex CPRred –CYP21–SCYP21;
y16, PCYP21; y17,NADPH; y18,CYP61ox;
y19, SCYP61; y20,CYP61–SCYP61;
y21, complex CPRred –CYP61;
y22, complex CPRred –CYP61–
SCYP61; y23, PCYP61.
The ordinary differential equation system then
reads:
y1′ = −k1y1y22 − k6y1y5 − k8y1y8
− k10y1y7 − k12y1y10 + k14y3y17
− k17y1y18 − k19y1y20
y2′ = 0
y3′ = k1y1y22 + k7y22y11 + k9y22y12
+ k11y2y13 + k13y2y15 − k14y3y17
+ k18y22y21 + k20y2y22
y4′ = k1y1y22 + k7y22y11 + k9y22y12
+ k18y22y21
y5′ = −k2y5y6 + k3y7 − k6y1y5
+ k7y22y11 + k11y2y13
y6′ = 0
y7′ = k2y5y6 − k3y7 − k10y1y7
y8′ = −k4y8y9 + k5y10 − k8y1y8
+ k9y22y12 + k13y2y15
y9′ = 0
y10′ = k4y8y9 − k5y10 − k12y1y10
y11′ = k6y1y5 − k7y22y11
y12′ = k8y1y8 − k9y22y12
y13′ = k10y1y7 − k11y2y13
y14′ = k11y2y13
y15′ = k12y1y10 − k13y2y15
y16′ = k13y2y15
y17′ = 0
y18′ = −k15y18y19 + k16y20 − k17y1y18
+ k18y22y21 + k20y2y22
y19′ = 0
y20′ = k15y18y19 − k16y20 − k19y1y20
y21′ = k17y1y18 − k18y22y21
y22′ = k19y1y20 − k20y2y22
y23′ = k20y2y22,
whereby the prime designates the first derivative
with respect to time. Due to the assumption of a
steady-state situation, the concentrations of oxygen
(y2), the CYP51 substrate (y6), the CYP21 sub-
strate (y9), the CYP61 substrate (y19) and NADPH
(y17) were regarded as remaining constant. As
indicated in Figure 4, either the concentration of
the CYP21 enzyme (y8) or the concentration of the
CYP21 substrate (y9) was subjected to variation.
Enzyme and substrate concentrations
By deduction from our own unpublished data, the
total amount CYP21 enzyme was estimated to be
5 nmol/l of yeast culture. The biotransforming cul-
ture was regarded as a two-phase system and, using
an average cell volume of 120 µm3 (Kubitschek
and Ward, 1985), the productive biomass volume
of 1 l of culture with a density of 5 × 107 cells/ml
was calculated to be 6 ml. This volume is actually
harbouring the CYP21; consequently, the effec-
tive CYP21 concentration (y8) is not 5 nM but
approximately 830 nM in the biomass phase. Data
on the amounts of the relevant endogenous fission
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yeast proteins are not available and were arbitrar-
ily set to 83 nM for CYP51ox and CYP61ox (y5
and y18, respectively) and 8.3 nM for CPRred (y1).
By deduction from water solubility data for proges-
terone and 17α-hydroxyprogesterone (Yang et al.,
2002), the effective intracellular concentrations of
the CYP21 substrates were assumed to be 40 µM
and 150 µM, respectively. For the CYP51 substrate
lanosterol, data gained with anaerobic fission yeast
yielded 0.8 µg sterol/mg protein and a lanosterol
ratio of 4.5% of total sterols. Taking into account
the molecular weight of 426.72 g/mol for lanos-
terol and an average protein content of 10 pg/cell,
the lanosterol mole amount per liter culture is 42
nM, which gives roughly 7000 nM (y6) for the
biomass phase. It was thus concluded that endoge-
nous CYP51 and CYP61 were virtually saturated
with their substrates if we further assume a concen-
tration for the CYP61 substrate ergosta-5,7-dienol
(y19), similar to lanosterol. From data reported by
Vaseghi et al. (1999) and Lloyd et al. (1983), the
intracellular concentrations of NADPH and oxy-
gen were estimated to be constantly 150 µM and
500 nM, respectively.
Rate constants
From the data presented in this work, it can
be deduced that the formation rates of proges-
terone and 17α-hydroxyprogesterone are approx-
imately 1 µM/h (= 17 nM/min) and 10 µM/h (=
170 nM/min), respectively, and remain essentially
constant during the first 24 h. Together with the
values given above, this yields k13 = 0.02 nM/min
for progesterone and k13 = 0.2 nM/min for 17α-
hydroxyprogesterone, respectively. Using vmax =
6 nmol/min/nmol P450 (Kelly et al., 1997) gives
k11 = k20 = 0.07 nM/min for both CYP51 and
CYP61. The rate constants for substrate binding
to the CYP21 were set to k4 = 0.0003 nM/min
and k5 = 18 nM/min according to data gained
from liposome assays (Kominami et al., 1986).
The same substrate kinetics was applied to all
constituent P450s in the system. With vmax =
700 nmol/min/nmol CPR for either the NADPH
oxidation or the cytochrome c reduction (Lamb
et al., 2001) and 8.3 nM (y1) we used k6 =
k10 = k14 = k17 = k19 = 84/nM/min. The inter-
action between fission yeast CPR and human
CYP21 (k8, k12) was assumed to have the same
rate constant as between the endogenous P450s and
CPR. For ROS production by CPR (k1), CYP51
(k7) and CYP61 (k18), respectively, we assumed
a rate that corresponds to 10% of the product rate
constant, yielding 0.008/nM2/ min for CPR and
0.007/nM2/min for both CYP51 and CYP61.
Summary of all parameters
All the following concentrations are nanomolar and
the rate constants are per minute (see respective
reaction for first- or second-order dimensions).
Initial concentrations were:
y01 = 8.3, y02 = 500, y03 = 0, y04 = 0,
y05 = 83, y06 = 7000, y07 = 0, y010 = 0,
y011 = 0, y012 = 0, y013 = 0, y014 = 0,
y015 = 0, y016 = 0, y017 = 150000,
y018 = 83; y019 = 7000; y020 = 0;
y021 = 0; y022 = 0 and y023 = 0.
Rate constants were:
k1 = 0.008, k2 = 0.0003, k3 = 18,
k4 = 0.0003, k5 = 18, k6 = 84, k7 = 0.007,
k8 = 84, k9 = 0.007, k10 = 84, k11 = 0.07,
k12 = 84, k13 = 0.02 or 0.2, k14 = 84,
k15 = 0.0003, k16 = 18, k17 = 84,
k18 = 0.007, k19 = 84, k20 = 0.07.
The equation system was numerically integrated
using the ode15s solver algorithm (MATLAB;
Natick, MA).
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Abstract
Human steroid 21-hydroxylase (CYP21) and steroid 17a-hydroxylase/17,20-lyase (CYP17) are two closely related
cytochrome P450 enzymes involved in the steroidogenesis of glucocorticoids, mineralocorticoids, and sex hormones,
respectively. Compounds that inhibit CYP17 activity are of pharmacological interest as they could be used for the treatment of
prostate cancer. However, in many cases little is known about a possible co-inhibition of CYP21 activity by CYP17 inhibitors,
which would greatly reduce their pharmacological value. We have previously shown that ﬁssion yeast strains expressing
mammalian cytochrome P450 steroid hydroxylases are suitable systems for whole-cell conversion of steroids and may be used
for biotechnological applications or for screening of inhibitors. In this study, we developed a very simple and fast method for
the determination of enzyme inhibition using Schizosaccharomyces pombe strains that functionally express either human CYP17
or CYP21. Using this system we tested several compounds of different structural classes with known CYP17 inhibitory
potency (i.e. Sa 40, YZ5ay, BW33, and ketoconazole) and determined IC50 values that were about one order of magnitude
higher in comparison to data previously reported using human testes microsomes. One compound, YZ5ay, was found to be a
moderate CYP21 inhibitor with an IC50 value of 15mM, which is about eight-fold higher than the value determined for
CYP17 inhibition (1.8mM) in ﬁssion yeast. We conclude that, in principle, co-inhibition of CYP21 by CYP17 inhibitors
cannot be ruled out.
Keywords: CYP17, CYP21, fission yeast, prostate cancer, Schizosaccharomyces pombe, inhibition, 17a-hydroxylase/17,20-
lyase, steroid 21-hydroxylase
Introduction
Prostate cancer is the second leading cause of death
from cancer and the most prevalent cancer amongst
men in the western world. Since approximately 80%
of human prostatic tumors are androgen dependent,
inhibitors of enzymes involved in the key steps of
androgen synthesis are of potential pharmacological
importance. The cytochrome P450 dependent steroid
17a-hydroxylase/17,20-lyase (CYP17) is one of these
key target enzymes [1,2] as it catalyzes the 17a-
hydroxylation of pregnenolone (Preg) and progester-
one (Prog) and the subsequent cleavage of the
C20,21-acetyl group to yield dehydroepiandrosterone
(DHEA) and androstenedione (AD), respectively [3].
As CYP17 is expressed in the adrenals and testes [4],
its inhibition should decrease the production of both
testicular and adrenal androgens. Ketoconazole, an
antimycotic and unspeciﬁc inhibitor of several CYP
enzymes that also inhibits CYP17, has been used
clinically in the treatment of advanced prostate cancer
[5–7]. Although this compound had shown anti-
tumor activity, it was withdrawn from clinical use
because of its short half-life and its non-selective side
effects. Consequently, several research groups have
aimed for new steroidal and non-steroidal compounds
with CYP17 inhibitory potency [1,8–13]. However,
little information has been available so far about a
possible co-inhibition of steroid 21-hydroxylase
(CYP21) by these compounds. Human CYP21 is a
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microsomal cytochrome P450 enzyme that is closely
related to CYP17 and converts Prog to 11-deoxycor-
ticosterone (DOC) and 17a-hydroxyprogesterone
(17Prog) to 11-deoxycortisol (RSS). The activity
of this enzyme is essential for the formation of gluco-
and mineralocorticoids, and its impairment causes
congenital adrenal hyperplasia (CAH) [14,15], the
most frequent inherited disorder of steroid metab-
olism. In these patients, adrenocorticotropic hormone
(ACTH) levels increase because of defective cortisol
synthesis, which results in overproduction and
accumulation of cortisol precursors, particularly
17Prog proximal to the block. This in turn causes
excessive production of androgens and results in
virilization [16]. Human CYP17 and CYP21 differ by
only 14 amino acids in length, share 29% amino acid
identity, and hydroxylate their steroidal substrates at
two carbon atoms that lie a mere 0.26 nm apart.
Moreover, the CYP17 and CYP21B genes have
identical intron/exon organization [17,18], and are
very closely related from an evolutionary point of view
[19]. But while the only activities that have been
demonstrated for CYP21 are the two 21-hydroxy-
lation reactions mentioned above, CYP17 is not only a
17a-hydroxylase and a 17,20-lyase, but can also
display 16a-hydroxylase and D16-ene synthase activi-
ties [20]. Both enzymes share the common substrate
Prog, and at least some compounds (e.g. the
enantiomer of Prog [21]) competitively inhibit
progesterone metabolism of both enzymes. Thus, it
cannot a priori be ruled out that CYP17 inhibitors
signiﬁcantly inhibit CYP21, which would greatly
reduce their pharmacological value. The aim of this
study was to develop a rapid and convenient test
system that identiﬁes compounds with inhibitory
potency towards CYP17 and CYP21. For this
purpose we made use of recombinant ﬁssion yeast
strains that strongly express either human CYP17 or
CYP21, respectively, and display high steroid
hydroxylation activity. Three CYP17 inhibitors that
belong to different structural classes were tested with
these strains and the resulting data were compared to
the effect of ketoconazole.
Materials and methods
Chemicals
Radioactive [14C]progesterone was obtained from
NEN (Boston, MA), non-radioactive steroids and
ketoconazole were from Sigma (Deisenhofen,
Germany). The CYP17 inhibitors Sa 40 [12], YA5ay
[11] and BW33 [22] have been described before.
Fission yeast strains and culture
Fission yeast strain CAD18 (all genotypes are listed in
Table I) has been described previously [23]. Brieﬂy, it is
a derivative of parental strainMB175 [24] and contains
the human P450 gene cloned into plasmid pNMT-
TOPOw (Invitrogen; Carlsbad, CA) that allows strong
expression under the control of the nmt1 promoter
[25].Using pNMT-TOPOw the proteins of interest are
expressedwith twoC-terminal tags, a hexahistidine tag
and a Pk tag, respectively; the latter allows convenient
immunological detection of the proteins [26]. Media
and genetic methods for studying ﬁssion yeast have
been described in detail [27,28]. Generally, strains
were cultivated at 308C in Edinburgh Minimal
Medium (EMM) with supplements (ﬁnal concen-
tration 0.1 g·L21) of adenine, leucine, histidine, and
uracil, respectively, as required. Thiamine was used at
a concentration of 5mM throughout. General DNA
manipulation methods were performed using standard
techniques [29].
Construction of a fission yeast strain expressing human
CYP17
The cDNA of human CYP17 was PCR-ampliﬁed
using Pyrococcus furiosus (Pfu) DNA polymerase
(Promega; Madison, WI) and cloned into the ﬁssion
yeast expression vector pNMT1-TOPOw (Invitrogen)
to give pNMT1-hCYP17. Fission yeast strain MB175
was the transformed with this plasmid by the
lithium acetate method [28] to yield strain CAD8
(all genotypes are listed in Table I). Transformed cells
were plated on EMM with 0.1 g·L21 adenine,
histidine, uracil and 5mM thiamine and incubated at
308C. Transformants were checked for plasmid
incorporation by colony PCR.
Protein detection
Early stationary phase cultures were used for
denaturing protein extraction, where a total amount
of approximately 2.5·108 cells were processed as
previously described [23]. Protein preparation, SDS-
PAGE and Western blot analysis were performed
using standard techniques [29]. An a-Pk antibody
(MCA1360, Serotec; Oxford, England) and a
secondary peroxidase coupled a-rabbit antibody
(DakoCytomation; Glostrup, Denmark) were used
Table I. Parental strain and derived strains used in this work.
Strain Genotype Expressed P450 Reference
MB175 h- ade6.M210 leu1.32 ura4.dl18 his3.D1 none [24]
CAD8 h- ade6.M210 leu1.32 ura4.dl18 his3.D1 / pNMT1-hCYP17 CYP17 this work
CAD18 h- ade6.M210 leu1.32 ura4.dl18 his3.D1 / pNMT1-hCYP21 CYP21 [23]
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for immunologic detection. Visualization was done
using 2.0mL of 2mg·mL21 chloronaphthol in 98%
EtOHmixed with 25mL PBS and 10ml H2O2 (30%).
Medium scale steroid hydroxylation assays
For steroid bioconversion, cells were grown to early
stationary phase in EMM with supplementes but
without thiamine, centrifuged, washed and resus-
pended in 10mL of the same media to a cell density of
approximately 5·107 cells·mL21. The cell suspension
was then transferred to a 250mL Erlenmeyer ﬂask,
steroid substrate was added to a ﬁnal concentration of
1.0mM, and the culture was shaken for 72 h at 308C
and 300 rpm. Samples were taken at 0 h, 24 h, 48 h,
and 72 h, respectively. Steroids were extracted with an
equal volume of chloroform and analyzed on a HPLC
device (Jasco; Tokyo, Japan) composed of an auto-
sampler AS-950, pump PU-980, gradient mixer LG-
980-02 and an UV-detector UV-975 equipped with a
reversed phase Nova-Pakw C18 column (Waters;
Milford, MA). The mobile phase was methanol:water
(60:40) yielding retention times around 45min for
Prog, 20min for 17Prog, 16.5min for DOC and
10min for RSS. Absorption was recorded at 240 nm
and peak detection was done using the algorithm of
the analysis software BorwinTM v1.50 (Jasco).
Dilutions of respective pure steroids were used as
references and as internal standard references as well
as for calibrations. In the case of Preg conversion by
CAD8, steroids had to be converted to the 4-ene-3-
one species by cholesterol oxidase (Serva; Heidelberg,
Germany) in order to be detectable at 240 nm. As the
activity of cholesterol oxidase is signiﬁcantly decreased
at the low pH values [30] that are typical for ﬁssion
yeast cultures, Preg conversion was only qualitatively
described but not used for quantitative analysis of
steroid hydroxylation activity or inhibitor assays.
Screening procedure and determination of IC50 values
Early stationary phase ﬁssion yeast cultures were used
for miniaturized steroid hydroxylation assays. For
each sample, 500mL of cell suspension was trans-
ferred to 1.5mL Eppendorf tubes and preincubated
for 15min at 308C and 1400 rpm in a benchtop shaker
with different inhibitor concentrations as indicated.
After substrate addition, cells were incubated for
further a 15min. Inhibitor concentrations ranged
from 100nM to 20mM while progesterone concen-
tration was always 100 nM and included [14C]pro-
gesterone for radiocative detection. The reaction was
stopped by chloroform extraction of steroids using
whole cultures. The organic phase was dried under
vacuum, steroids were dissolved in 10mL of chloro-
form and spotted on to glass-backed silica-coated
HPTLC plates (Kieselgel 60 F254, Merck; Darmstadt,
Germany). In addition, small amounts of nonradioac-
tive steroids were spotted as references. The HPTLC
was developed twice in chloroform/methanol/water
(300:20:1), and steroids were identiﬁed after exposure
to Fuji imaging plates. Quantiﬁcation was done using
a phosphoimager (BAS-2500, Fuji; Stamford, CT)
and the software TINA v2.10 g. The ratio R of the
respective products was calculated as follows:
R17Prog ¼
I17Prog
I17Prog þ I16Prog þ IBp þ IProg
; ð1Þ
RDoc ¼
IDOC
IDOC þ IProg
; ð2Þ
where I is the intensity of the respective steroid as
measured by the phosphoimager and the subscript Bp
denotes the byproduct (see below). Multiplication of
the ratios by the initial concentration of substrate
steroid gave the concentration of each steroid at every
time point.
Results
Expression of human CYP17 in fission yeast strain CAD8
Fission yeast strain MB175 was transformed using
pNMT1-hCYP17 as described above. After three
days, the presence of the CYP17 cDNA in colonies
grown on selective media was conﬁrmed by colony
PCR. The resulting strain was named CAD8. For
immunologic detection of the human CYP17 protein,
yeasts were grown in the absence of thiamine to induce
the strong nmt1 promoter. Protein lysates were
prepared from CAD8 as well as from parental strain
MB175 and examined by Western blot analysis using
an a-Pk antibody. As expected, the presence of
CYP17 could be detected in lysates from CAD8 but
not in the parental strain (Figure 1A), and the
antibody showed no cross-reaction with other ﬁssion
yeast proteins.
Steroid bioconversion by strain CAD8
The functionality of the human CYP17 enzyme
expressed in S. pombe was conﬁrmed by steroid
hydroxylation assays monitoring the conversion of
Prog and Preg as described above. Both substrates
were successfully converted to the respective
17a-hydroxylated products after 72 hours
(Figures 1B to 1E). During the ﬁrst 24 hours,
176 ^ 13mM 17Prog and 83 ^ 9mM 16Prog were
produced (Figures 1F and 1G). The concentration-
time course is pseudoﬁrst-order for t , 48 hours.
CYP17 is a microsomal enzyme that in mammalian
cells receives electrons from NADPH via the
NADPH-cytochrome P450 reductase (CPR), and
our results demonstrate that the heterologously
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expressed human enzyme is also efﬁciently reduced by
ccr1, the ﬁssion yeast CPR homologue [31]. During all
experiments, formation of AD or of DHEA (resulting
from AD after cholesterol oxidase treatment) was
never detected, which indicates that human CYP17
expressed in ﬁssion yeast does not catalyze the steroid
17,20-lyase reaction under these conditions.
Establishment of a cellular inhibitor assay using fission
yeast that expresses either CYP17 or CYP21 and
validation of CYP17 inhibition
The functional expression of human CYP21 in S.
pombe was previously shown by us [23], and the
functionality of human CYP17 in this yeast is
demonstrated in this study. As a ﬁrst step towards
the set-up of an inhibitor testing procedure, we
monitored the conversion of progesterone (Prog) by
CYP17 to 17a-hydroxyprogesterone (17Prog) and
16a-hydroxyprogesterone (16Prog), and the CYP21-
dependent hydroxylation of Prog to 11-deoxycorti-
costerone (DOC), respectively, in miniaturized
steroid hydroxylation assays as described above.
Under these conditions that employ lower substrate
concentrations (100 nM), strain CAD18 (expressing
CYP21) converted Prog to DOC virtually to
completion within 3 hours without the detectable
formation of byproducts (Figure 2). Strain CAD8
(expressing CYP17) converted Prog to 17Prog,
16Prog and a byproduct that appears to be more
polar than 16Prog and 17Prog (data not shown). No
substrate conversion was observed when using the
parental strain MB175 (data not shown). The
apparent rate constant of substrate consumption
could be determined by ﬁtting the decay function,
cðtÞ ¼ c0exp ð2kapptÞ ð3Þ
with c(t) being the concentration as a time dependent
function and kapp the apparent substrate consumption
rate constant.Data analysis yieldedkapp ¼ 2.7 ^ 0.1h
21
for strainCAD8 (correlation coefﬁcient r 2 ¼ 0.996) and
kapp ¼ 2.5 ^ 0.1 h
21 for CAD18 (r 2 ¼ 0.991).
Figure 1. Fission yeast strain CAD8 expressing the human CYP17 can convert progesterone to 17a(hydroxyprogesterone. A: Immunologic
detection of CYP17 heterologously expressed in strain CAD8. Protein extraction and detection were done as described above. The indicated
band is in good agreement with the calculated mass of 59 kDa. PM: protein marker; WT: parental strain (MB175); CAD8: CYP17 expressing
strain. B, C, D and E: HPLC chromatograms of steroid hydroxylation assays using strain CAD8 as described above. Prog: progesterone,
17Prog: 17a(hydroxyprogesterone), 16Prog: 16a(hydroxyprogesterone), DOC: 11(deoxycorticosterone (internal standard)), *: an
unidentiﬁed compound that was also detected in the absence of steroid substrates (data not shown). B and C Conversion of 1.0mM
progesterone by strain CAD8 for 72 h.Dand EConversion of 1.0mM pregnenolone by strain CAD8 for 72h. Prior to steroid extraction with
chloroform, the cell suspension was incubated with cholesterol oxidase (see above) in order to convert the D5–steroids into D4–species. F and
G: Concentration increase of 17a(hydroxyprogesterone) (F) and 16a(hydroxyprogesterone) (G) measured during the bioconversion assay
with CAD8 incubated with 1.0mM progesterone. All values were calculated from extraction loss corrected peak areas using calibration with
pure steroids and represent mean ^ standard error of mean from three independent experiments.
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As before, no products of 17,20-lyase activity of CYP17
were detected. Due to these ﬁndings, the assay period
could conveniently be set to 15min, where both strains
caused between 25 and 40% substrate conversion.Next,
we used strain CAD8 to test for the inhibitory action of
the broad range P450 inhibitor ketoconazole [32] and of
the speciﬁc CYP17 inhibitors Sa 40 [12], YZ5ay [11],
and BW33 [22] (all structures are shown in Figure 3).
Since 17,20-lyase activity was not observed, inhibitory
action refers only to the 17a-/16a-hydroxylase activity of
CYP17.Ataconcentrationof100nM,noneof the tested
compounds displayed a strong inhibition, while at
500nM, Sa 40 acted as the most potent inhibitor; at
20mM, all three speciﬁc inhibitors but not ketoconazole
strongly reduced CYP17 activity (Table II). IC50 values
calculated from these data are presented in Table III.
These results indicate that ﬁssion yeasts expressing
humanCYP17 are suitable for rapid inhibitor screening,
although higher inhibitor concentrations were required
than in previous assays with human testes microsomes
(see Discussion).
Determination of inhibitory action of CYP17 inhibitors on
human CYP21
Next, ﬁssion yeast strain CAD18 was used for the
determination of IC50 values as described in above. An
representative experiment is shown inFigure 4, showing
the inhibition of CYP21 activity by increasing concen-
trations of compound YZ5ay. Data calculated from six
independent experiments for eachcompoundare shown
in Figure 5, and the percent inhibition values for the
highest inhibitor concentration used (20mM) are given
in Table II. In general, all tested compounds inhibited
CYP21 less efﬁciently than CYP17, with YZ5ay being
the only compound to cause more than 50% inhibition
at a concentration of 20mM. Inhibition data points of
YZ5ay for the fourhighest inhibitor concentrationswere
used to calculate an IC50 of 15mM (Table III).
Compounds Sa 40 and BW33 were not accessible to
reliable IC50 determinations as no inhibition values of
more than 50% could be measured. Additionally, we
observed anunexpected activation ofCAD18-mediated
progesterone conversion by ketoconazole of 7%at 2mM
and 15% at 5mM (Figure 5). This behavior reversed
into inhibition at concentrations of more than 10mM.
To eliminate the possibility of a slower diffusion of
ketoconazole into the cells and, therefore, of limited
access of this compound to CYP21, the time
dependence of the product formation ratio on the
length of ketoconazole incubation was examined
(Figure 6). Cells of strain CAD18 were pre-incubated
with5mMketoconazole for different timeperiods,while
a 60minute incubation with solvent alone served as
control. Prog was then added to all samples, and the
steroid conversion assay was performed for 15minutes
as above. This experiment surprisingly showed that
CYP21 activity signiﬁcantly increases with a longer pre-
incubation with ketoconazole, which excludes the
notion that delayed diffusion of ketoconazole into the
cells could account for the weak inhibitory action of this
compound in this test system.
Discussion
Heterologous expression of functional human CYP17
in fission yeast
Fission yeast cells strongly expressing human CYP17
did not show an altered microscopic phenotype, grew
within one day to early stationary phase under induced
conditions (i.e., in the absence of thiamine) and could
be directly used for each of the described methods.
Western blot analysis of the expressed CYP17 protein
revealed a strong band in the expected size range and
some additional bands (Figure 1A). Multiple bands
in SDS/PAGE were also detected when either
Figure 2. Time course of product formation of ﬁssion yeast strains
expressing human CYP17 and CYP21. Miniaturized steroid
conversion assays were carried out as described in “Materials and
methods” with 100nM progesterone. Samples were taken at the
indicated time points, separated by HPTLC and analyzed using a
PhosphoImager. Ratios were calculated using Equations (1) and (2)
(for the byproducts of the CAD8 assay, Equation (1) was
rearranged). Prog: progesterone; DOC: 11-deoxycorticosterone;
17Prog: 17a-hydroxyprogesterone; 16Prog: 16a-hydroxy
progesterone; Bp: byproduct.
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Escherichia coli [33] or Saccharomyces cerevisiae [34,35]
were used as a host for the expression of human
CYP17. Even in the case of COS-1 (African green
monkey kidney) cells expressing bovine CYP17, two
bands of different intensity were detected [36]. In all
studies including this one, the distance between the
two highest protein bands indicates a mass difference
of roughly 10 kDa, which is by far too large to be
accounted for by the loss of the localization signal in
the mature protein as compared to the preprotein.
Therefore, we assume that overexpressed CYP17 is
readily degraded by speciﬁc proteolysis, which seems
to invariably occur in different hosts including
mammalian cells.
The functionality of the human CYP17 enzyme
expressed in ﬁssion yeast was demonstrated by in vivo
conversion assays using the natural substrates Preg
and Prog (Figure 1). We observed a distinct 17a- and
16a-hydroxylase activity of CAD8 towards Preg and
Prog, but no detectable 17,20-lyase activity. This
suggests that the human P450 can successfully couple
to the ﬁssion yeast NADPH P450 oxidoreductase
(CPR) ccr1.
It has been described that the 17,20-lyase activity of
human CYP17 is not only dependent on electron
delivery from CPR but can be augmented by the
presence of cytochrome b5, even when the latter is not
involved in electron transfer itself [34]. It is intriguing
that S. pombe lacks this function, although its own
cytochrome b5 shares 33% identity and 55% similarity
with the human homologue. But Saccharomyces
cerevisiae strains expressing bovine CYP17 also
exhibited poor 17,20-lyase activity towards
17a-hydroxypregnenolone and nearly none towards
17Prog [37–39]; however, lyase activity was enhanced
after co-expression of human cytochrome b5 [34].
Furthermore, human CYP17 expressed in E. coli and
reconstituted with rat CPR showed no detectable lyase
activity for 17Prog [33]. Recently, a classiﬁcation
system for CYP17 enzymes from different species was
suggested, in which the human and the bovine enzyme
are part of the group B CYP17s, which have no or
insigniﬁcant 17,20-lyase activities in relation to
17Prog [40].
As shown in Figure 1, we detected a byproduct in
the 100 nM substrate conversion assays that appeared
to be formed only after CYP17 expression (strain
CAD8) and not in strains MB175 or CAD18. This
strongly points towards a reaction that takes place
downstream of the Prog ! 17Prog/16Prog reaction,
whereby the precursor of the byproduct (i.e., either
16Prog or 17Prog) remains to be identiﬁed. In order
to answer this question by using the time course data
obtained in this study, two potential mechanisms can
be postulated with rate constants (k) indicated above
and below the arrows. InModel A, the byproduct (Bp)
is made from 17Prog in a reversible reaction:
Prog!
k1
17ProgY
k3
k4
Bp
#
k2
16Prog
ð4Þ
By contrast, Model B assumes that Bp is made from
16Prog in a reversible reaction:
Prog!
k1
17Prog
#k2
16ProgY
k3
k4
Bp
ð5Þ
Figure 3. Structures of compounds used in this study.
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Unfortunately the solution set of the dynamic linear
equation system is inﬁnite for both models. However,
for times t # 0.5 h we can assume a slow backward
reaction of Bp due to relatively low byproduct
concentrations bringing about an error of approxi-
mately 15% to the solution. Consequently, within the
ﬁrst 30minutes we further assume the reactions
of 17Prog and 16Prog to be described by c(t) ¼ c0
(1(exp((kit)), where ki (i ¼ 1,2) is the apparent
substrate consumption rate constant for either
17Prog or 16Prog. Data ﬁtting yielded
k1 ¼ 1.61^0.1 h
21 and k2 ¼ 0.43 ^ 0.04 h
21. The
rate constant for the byproduct reaction was found to
be k3 ¼ 0.07 ^ 0.01 h
21. The differential equation
system was solved numerically using MATLAB’s
ode45 solver (Natick, Massachusetts, USA) yielding
the data presented in Figure 7. Comparison of the
simulated versus the experimentally gained data
strongly suggests that Bp is made from 17Prog. In
case model B would hold, there should be a decrease
in 16Prog over time and no signiﬁcant built up of Bp.
Furthermore, there should be no decrease in 17Prog.
The decreasing slope of the concentration time course
of Bp (Figure 2A) indicates that the back reaction has
a rate greater than the Bp production, which was
roughly estimated to be about 2 to 4 times higher than
k3 (k4 ¼ 3k3 in simulation). Remarkably, at low
substrate concentrations the steroid conversion rates
for CYP17 and CYP21 are roughly equal although
there are great differences at 1.0mM progesterone,
where, in agreement with the literature [23], the
apparent production rate is ten times lower for DOC
than for 17Prog. In bakers yeast expressing CYP17, an
endogenous 20a-hydroxysteroid dehydrogenase
(20a-HSD) was shown to convert 17Prog to
17a,20a-dihydroxypregn-4-ene-3-on [39], and
S. pombe was also reported to exhibit 20a-HSD
activity towards progesterone [41]; in this study, we
observed a weak progesterone conversion by wild type
ﬁssion yeast only at higher substrate concentrations
(data not shown). Taken together, it can be assumed
that the unidentiﬁed byproduct is 17a,20a-dihydrox-
ypregn-4-ene-3-one.
IC50 determination with fission yeast expressing human
microsomal P450 enzymes
In this study, we report the creation of a ﬁssion yeast
based test system suited for the determination of IC50
values of inhibitory compounds acting on human
CYP17 and CYP21 with an assay duration time of
15min. The validity of this system was shown by
testing three known CYP17 inhibitors with high
potency (Sa 40 [12], YZ5ay [11], and BW33 [42])
and ketoconazole [32]. A comparison of IC50 values
previously determined in assays using testes micro-
somal preparations of human CYP17 with data
obtained in this study shows that higher inhibitorT
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concentrations are needed in the ﬁssion yeast test
system to reduce CYP17 activity (Table III). In human
testes microsomes, the IC50 value of ketoconazole for
the inhibition of CYP17 was found to be 740 nM [11],
while this compound inhibited CYP21 only weakly
[7,43]. This is also reﬂected by our ﬁssion yeast
results, where ketoconazole was found to be an
ineffective inhibitor of CYP17 or CYP21 even at a
concentration of 20mM (Table II). Of the speciﬁc
CYP17 inhibitors tested here, only YZ5ay displayed
signiﬁcant inhibitory potency towards CYP21, while
Sa 40 and BW33 showed a strong selectivity towards
CYP17. Even in the case of YZ5ay, the selectivity of
this compound is about eight-fold higher towards
CYP17 than towards CYP21. Still, these ﬁndings
corroborate our initial apprehension that CYP17
inhibitors may also co-inhibit CYP21 and stress the
necessity to test drug candidates for this co-inhibitory
effect.
Table III. Comparison of IC50 values of selected CYP17 inhibitors determined either in human testes microsomes or in ﬁssion yeast strains
CAD8 or CAD18, respectively.
Compound IC50 CYP17 in microsomes (mM) IC50 CYP17 in ﬁssion yeast (mM) IC50 CYP21 in ﬁssion yeast (mM)
Sa 40 0.024 [12] 0.8 n.d.
YZ5ay 0.24 [11] 1.8 15
BW33 0.11 [42] 2.8 n.d.
n.d.: Not determined.
Figure 4. Autoradiographic detection of steroid hydroxylation activity. Cells of strain CAD18 were incubated with increasing concentrations
of the CYP17 inhibitor YZ5ay as described in “Materials and methods”. Steroids were extracted with chloroform, separated by HPTLC and
analyzed using a PhosphoImager. CO: control reaction of strain CAD18 cells (solvent only). Subsequent six lanes contain CAD18 incubations
with increasing concentrations of YZ5ay from the left to the right. Prog: progesterone (substrate); DOC: 11-deoxycorticosterone (product)
Figure 5. Log inhibitor concentration(CYP21 inhibition plot for
all tested compounds. CAD18 cells were incubated with 100nM
progesterone and increasing concentrations of the different
compounds as described in “Materials and methods”. Ratios of
DOC were normalized to the control reaction and plotted on a half
logarithmic scale.
Figure 6. Activating effect of ketoconazole on human CYP21
expressed in ﬁssion yeast. Cells of strain CAD18 were incubated
with 100nM progesterone and 5.0mM ketoconazole for different
time periods as indicated. The ratio of DOC at the end of the
incubation period was measured as described in “Materials and
methods”. 60min sol.: Sample incubated for 60minutes with
solvent only (control).
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